index	sentence	label
0	Acylcarnitines have been suggested to play a role in @PROTEIN$ resistance, as well as other @COMPOUND$ metabolites.	0
1	In the present study we investigated whether muscle long-chain acylcarnitines increase during fasting and we investigated their relationship with @COMPOUND$/fat oxidation and @PROTEIN$ sensitivity in lean healthy humans.	0
2	We evaluated whether inhibition of @PROTEIN$ (hsp90) function by @COMPOUND$ derivatives could induce the degradation of signal transducers that drive cancer cell growth and thereby promote apoptosis.	1
3	We evaluated whether inhibition of heat shock protein 90 (@PROTEIN$) function by @COMPOUND$ derivatives could induce the degradation of signal transducers that drive cancer cell growth and thereby promote apoptosis.	1
4	As multidrug resistance (MDR) is a major problem in the chemotherapy of progressive breast cancer, the in vitro effects of Ad-REIC treatment were investigated in terms of the sensitivity of multidrug-resistant MCF7/ADR cells to @COMPOUND$ and of the P-@PROTEIN$ expression.	0
5	As multidrug resistance (MDR) is a major problem in the chemotherapy of progressive breast cancer, the in vitro effects of Ad-@PROTEIN$ treatment were investigated in terms of the sensitivity of multidrug-resistant MCF7/ADR cells to @COMPOUND$ and of the P-glycoprotein expression.	0
6	Ad-REIC treatment in MCF7/ADR cells also downregulated P-glycoprotein expresssion through @PROTEIN$ activation, and sensitized its drug resistance against @COMPOUND$.	0
7	Ad-REIC treatment in MCF7/ADR cells also downregulated P-@PROTEIN$ expresssion through JNK activation, and sensitized its drug resistance against @COMPOUND$.	0
8	Ad-@PROTEIN$ treatment in MCF7/ADR cells also downregulated P-glycoprotein expresssion through JNK activation, and sensitized its drug resistance against @COMPOUND$.	1
9	@COMPOUND$-induced expression of the orphan nuclear receptor @PROTEIN$ in MA-10 Leydig cells involves a CaMKI pathway.	1
10	@COMPOUND$-induced expression of the orphan nuclear receptor Nur77 in MA-10 Leydig cells involves a @PROTEIN$ pathway.	1
11	In Leydig cells, androgen biosynthesis is controlled primarily by the pituitary gonadotropin luteinizing hormone (LH) acting via its receptor (LH-R), which in turn activates the @PROTEIN$/@COMPOUND$ (cAMP) signaling pathway.	1
12	In Leydig cells, androgen biosynthesis is controlled primarily by the pituitary gonadotropin luteinizing hormone (LH) acting via its receptor (LH-R), which in turn activates the @PROTEIN$/cyclic adenosine monophosphate (@COMPOUND$) signaling pathway.	1
13	Here, we report that @COMPOUND$-mediated induction of @PROTEIN$ expression at the protein, mRNA, and promoter levels in MA-10 cells involves different mechanisms.	1
14	In addition, our detailed analysis of the @PROTEIN$ promoter in MA-10 cells revealed that distinct regulatory elements are involved in basal and @COMPOUND$-induced Nur77 transcription.	1
15	The use of lipoproteins as a substrate for @COMPOUND$ synthesis remains unclear, and the expression of lipoprotein receptors (very-low-density lipoprotein receptor (@PROTEIN$), low-density lipoprotein receptor (LDLR), and scavenger receptor-BI (SR-BI 12 h) has not been characterized.	0
16	The use of lipoproteins as a substrate for @COMPOUND$ synthesis remains unclear, and the expression of lipoprotein receptors (very-@PROTEIN$ (VLDLR), low-density lipoprotein receptor (LDLR), and scavenger receptor-BI (SR-BI 12 h) has not been characterized.	0
17	The use of lipoproteins as a substrate for @COMPOUND$ synthesis remains unclear, and the expression of lipoprotein receptors (very-low-density lipoprotein receptor (VLDLR), low-density lipoprotein receptor (LDLR), and scavenger receptor-BI (@PROTEIN$ 12 h) has not been characterized.	0
18	The use of lipoproteins as a substrate for @COMPOUND$ synthesis remains unclear, and the expression of lipoprotein receptors (very-low-density lipoprotein receptor (V@PROTEIN$), low-density lipoprotein receptor (LDLR), and scavenger receptor-BI (SR-BI 12 h) has not been characterized.	0
19	These data suggest that an ovulatory stimulus rapidly mobilizes stored cholesterol esters for use as a @COMPOUND$ substrate and that as these are depleted, new cholesterol esters are obtained through an LDLR- and/or @PROTEIN$-mediated mechanism.	0
20	These data suggest that an ovulatory stimulus rapidly mobilizes stored cholesterol esters for use as a @COMPOUND$ substrate and that as these are depleted, new cholesterol esters are obtained through an @PROTEIN$- and/or SR-BI-mediated mechanism.	0
21	Osteointegration of @COMPOUND$ or its alloy with bone can be greatly improved by calcium phosphate coatings, and further enhanced by an extracellular @PROTEIN$ layer such as collagen.	1
22	Osteointegration of titanium or its alloy with bone can be greatly improved by @COMPOUND$ coatings, and further enhanced by an extracellular @PROTEIN$ layer such as collagen.	0
23	Also, our previous studies implicated the SphK1/@PROTEIN$ pathway in the induction of the @COMPOUND$ cascade, a major inflammatory pathway involved in colon carcinogenesis.	1
24	In the azoxymethane (@COMPOUND$) murine model of colon cancer, SphK1 and @PROTEIN$ were significantly elevated in colon cancer tissues compared to normal mucosa.	1
25	In the @COMPOUND$ (AOM) murine model of colon cancer, SphK1 and @PROTEIN$ were significantly elevated in colon cancer tissues compared to normal mucosa.	1
26	We propose that the coordinated regulation of @PROTEIN$ cytoskeletal reorganization and macropinocytosis-mediated retrograde membrane trafficking may contribute to @COMPOUND$+)-induced axon growth inhibition.	1
27	Adult bone marrow (BM)-derived @PROTEIN$-producing cells (IPCs) are capable of regulating blood @COMPOUND$ levels in chemically induced hyperglycemic mice.	1
28	Treatment with @COMPOUND$ activated glucose metabolism in INS-1 cells in high-glucose culture conditions, and appeared to maximize the BM-derived IPCs ability to synthesize @PROTEIN$.	1
29	Treatment with benfotiamine activated @COMPOUND$ metabolism in INS-1 cells in high-glucose culture conditions, and appeared to maximize the BM-derived IPCs ability to synthesize @PROTEIN$.	0
30	Benfotiamine was not shown to induce the glucose receptor Glut-2, however it was shown to activate @PROTEIN$, the enzyme responsible for conversion of glucose to @COMPOUND$.	1
31	Benfotiamine was not shown to induce the glucose receptor @PROTEIN$, however it was shown to activate glucokinase, the enzyme responsible for conversion of glucose to @COMPOUND$.	0
32	@COMPOUND$ was not shown to induce the glucose receptor Glut-2, however it was shown to activate @PROTEIN$, the enzyme responsible for conversion of glucose to glucose-6-phosphate.	1
33	@COMPOUND$ was not shown to induce the glucose receptor @PROTEIN$, however it was shown to activate glucokinase, the enzyme responsible for conversion of glucose to glucose-6-phosphate.	0
34	However, in cells where the pentose phosphate pathway was blocked by @COMPOUND$ treatment, there was a clear downregulation of Glut-2, glucokinase, insulin, and @PROTEIN$.	1
35	However, in cells where the pentose phosphate pathway was blocked by @COMPOUND$ treatment, there was a clear downregulation of Glut-2, @PROTEIN$, insulin, and GAPDH.	1
36	However, in cells where the pentose phosphate pathway was blocked by @COMPOUND$ treatment, there was a clear downregulation of Glut-2, glucokinase, @PROTEIN$, and GAPDH.	1
37	However, in cells where the pentose phosphate pathway was blocked by @COMPOUND$ treatment, there was a clear downregulation of @PROTEIN$, glucokinase, insulin, and GAPDH.	1
38	Treatment with @PROTEIN$ indicates that the dimensions of the small fibrils may be dependent upon the presence of @COMPOUND$ within the matrix.	1
39	Mice lacking Niemann-Pick C1-Like 1 (@PROTEIN$) (NPC1L1 (-/-)mice) exhibit a defect in intestinal absorption of cholesterol and @COMPOUND$.	1
40	In this study, we examined the role of @PROTEIN$ in @COMPOUND$ and cholesterol trafficking in mice lacking ATP-binding cassette (ABC) transporters G5 and G8 (G5/G8(-/-) mice).	0
41	We found that mice lacking ABCG5/G8 and @PROTEIN$ (triple knockout (TKO) mice) did not accumulate @COMPOUND$ in plasma and the liver.	0
42	We found that mice lacking @PROTEIN$/G8 and NPC1L1 (triple knockout (TKO) mice) did not accumulate @COMPOUND$ in plasma and the liver.	0
43	In conclusion, @PROTEIN$ is essential for @COMPOUND$ to enter the body in mice.	1
44	Randomised trials have demonstrated that the efficacy of anti-tumour necrosis factor (@PROTEIN$) agents is significantly increased by concomitant @COMPOUND$ (MTX) in rheumatoid arthritis (RA).	1
45	Furthermore @COMPOUND$ treatment markedly decreased the levels of TNF-alpha, IL-6 and MCP-1, reduced myocardial infiltration of macrophages and significantly increased myocardial and serum levels of the anti-inflammatory cytokine @PROTEIN$.	1
46	Furthermore @COMPOUND$ treatment markedly decreased the levels of TNF-alpha, IL-6 and @PROTEIN$, reduced myocardial infiltration of macrophages and significantly increased myocardial and serum levels of the anti-inflammatory cytokine IL-10.	1
47	Furthermore @COMPOUND$ treatment markedly decreased the levels of TNF-alpha, @PROTEIN$ and MCP-1, reduced myocardial infiltration of macrophages and significantly increased myocardial and serum levels of the anti-inflammatory cytokine IL-10.	1
48	Furthermore @COMPOUND$ treatment markedly decreased the levels of @PROTEIN$, IL-6 and MCP-1, reduced myocardial infiltration of macrophages and significantly increased myocardial and serum levels of the anti-inflammatory cytokine IL-10.	1
49	Our study suggests that the modulation of the balance between pro- and anti-inflammatory cytokines towards the anti-inflammatory cytokine @PROTEIN$ is one salutary mechanism underlying how @COMPOUND$ influences post-MI remodelling and thus improves LV function.	1
50	The use of low-dose COCs is preferable in PCOS, especially among patients with @COMPOUND$ intolerance, @PROTEIN$ resistance and uncomplicated diabetes mellitus.	0
51	Using this method, we also determined whether streptozotocin-induced DM in rats (4-week duration) leads to changes in renal subcellular targeting of @PROTEIN$, and evaluated the effects of tight metabolic control (insulin, 12 IU/day) and angiotensin receptor blocker, @COMPOUND$ (4 weeks, 20 mg/kg/day).	0
52	Using this method, we also determined whether streptozotocin-induced DM in rats (4-week duration) leads to changes in renal subcellular targeting of CAV-1, and evaluated the effects of tight metabolic control (@PROTEIN$, 12 IU/day) and angiotensin receptor blocker, @COMPOUND$ (4 weeks, 20 mg/kg/day).	0
53	The involvement of @COMPOUND$ and nitric oxide was verified by the block of @PROTEIN$ using specific scavengers (tiron and PTIO, respectively).	0
54	The involvement of superoxide and nitric oxide was verified by the block of @PROTEIN$ using specific scavengers (@COMPOUND$ and PTIO, respectively).	1
55	The involvement of superoxide and @COMPOUND$ was verified by the block of @PROTEIN$ using specific scavengers (tiron and PTIO, respectively).	0
56	Accordingly, @PROTEIN$ were blocked by the peroxynitrite scavenger @COMPOUND$ and could be mimicked by application of exogenous peroxynitrite.	1
57	This conclusion is supported by our findings that @PROTEIN$ were suppressed by inhibitors of phospholipases but could be mimicked by exogenous phospholipases or by amphipaths (oleic acid, @COMPOUND$).	1
58	This conclusion is supported by our findings that @PROTEIN$ were suppressed by inhibitors of phospholipases but could be mimicked by exogenous phospholipases or by amphipaths (@COMPOUND$, Triton X-100).	1
59	@COMPOUND$ activity showed highest correlations to @PROTEIN$ II and microtubule targeting drugs.	1
60	Concentrations of aqueous-phase perfluorooctanoic acid (PFOA), a representative perfluorinated aliphatic (PFA) compound, are shown to be reduced effectively via reaction with horseradish peroxidase (@PROTEIN$), hydrogen peroxide, and a phenolic cosubstrate (@COMPOUND$).	1
61	Concentrations of aqueous-phase perfluorooctanoic acid (PFOA), a representative perfluorinated aliphatic (PFA) compound, are shown to be reduced effectively via reaction with horseradish @PROTEIN$ (HRP), hydrogen peroxide, and a phenolic cosubstrate (@COMPOUND$).	1
62	Concentrations of aqueous-phase perfluorooctanoic acid (PFOA), a representative perfluorinated aliphatic (PFA) compound, are shown to be reduced effectively via reaction with horseradish @PROTEIN$ (HRP), @COMPOUND$, and a phenolic cosubstrate (4-methoxyphenol).	1
63	Concentrations of aqueous-phase perfluorooctanoic acid (PFOA), a representative perfluorinated aliphatic (PFA) compound, are shown to be reduced effectively via reaction with horseradish peroxidase (@PROTEIN$), @COMPOUND$, and a phenolic cosubstrate (4-methoxyphenol).	1
64	Approximately 68% depletion of the parent compound and 98% depletion of its related acute aquatic toxicity are achieved in 6 h. Because no PFOA removal is observed in the absence of cosubstrate and/or following consumption thereof, we conclude that radical intermediate species generated during reaction between @PROTEIN$ and @COMPOUND$ mediate nonspecific depletion of PFOA and that these intermediates may be sufficiently reactive to sever the extremely stable C-F bonds of PFOA.	1
65	A 23.5-fold increase in @COMPOUND$ O-deethylation activity suggested that metabolic resistance through elevated levels of @PROTEIN$ dependent monooxygenase-activity is a possible resistance mechanism.However, synergism studies with different metabolic inhibitors revealed some contrasting resistance mechanisms between the METI-acaricides.	1
66	The activities of Rho GTPases are predominantly controlled by guanine nucleotide exchange factors (@PROTEIN$), which activate GTPases by catalyzing the exchange of bound @COMPOUND$ for GTP.	1
67	The estrogen-induced increase in @PROTEIN$ protein in MCF-7-HER2 cells was abrogated by the antiestrogen ICI 182780 and by gefitinib (@COMPOUND$ ; a phospho-tyrosine kinase inhibitor), indicating an ER-mediated effect and confirming involvement of receptor tyrosine kinases, respectively.	1
68	The estrogen-induced increase in @PROTEIN$ protein in MCF-7-HER2 cells was abrogated by the antiestrogen ICI 182780 and by @COMPOUND$ (Iressa ; a phospho-tyrosine kinase inhibitor), indicating an ER-mediated effect and confirming involvement of receptor tyrosine kinases, respectively.	1
69	The estrogen-induced increase in @PROTEIN$ protein in MCF-7-HER2 cells was abrogated by the antiestrogen @COMPOUND$ and by gefitinib (Iressa ; a phospho-tyrosine kinase inhibitor), indicating an ER-mediated effect and confirming involvement of receptor tyrosine kinases, respectively.	1
70	The enzyme responsible for D-@COMPOUND$ biosynthesis, @PROTEIN$ (SR), is therefore a promising target for treatment of neuropathologies related to glutamate receptor excitotoxicity, such as stroke or Alzheimer's disease.	1
71	Later-onset congenital central hypoventilation syndrome due to a heterozygous 24-@COMPOUND$ repeat expansion mutation in the @PROTEIN$ gene.	1
72	to describe a family with later onset congenital central hypoventilation syndrome (LO-CCHS) and heterozygosity for a 24-@COMPOUND$ repeat expansion mutation in the @PROTEIN$ gene, rendered phenotypically apparent with exposure to anesthetics.	1
73	Differential effects of @PROTEIN$ receptor activation by WAY 161503 on @COMPOUND$-induced place conditioning and locomotor activity in rats.	0
74	The capacity for osmotic adjustment, superoxide dismutase (@PROTEIN$) and ascorbate peroxidase (APX) activities and @COMPOUND$ content were also elevated in the transgenic Arabidopsis plants.	0
75	The capacity for osmotic adjustment, superoxide dismutase (SOD) and ascorbate peroxidase (@PROTEIN$) activities and @COMPOUND$ content were also elevated in the transgenic Arabidopsis plants.	0
76	The capacity for osmotic adjustment, @PROTEIN$ (SOD) and ascorbate peroxidase (APX) activities and @COMPOUND$ content were also elevated in the transgenic Arabidopsis plants.	0
77	To achieve enzymatic production of calcium-stearate at unfavorable conditions, i.e., pH 10 and 60 degrees C, suitable @PROTEIN$ was selected and reaction conditions were optimized using calcium @COMPOUND$ and hydrogenated beef tallow as substrates.	1
78	To achieve enzymatic production of @COMPOUND$ at unfavorable conditions, i.e., pH 10 and 60 degrees C, suitable @PROTEIN$ was selected and reaction conditions were optimized using calcium hydroxide and hydrogenated beef tallow as substrates.	1
79	Under optimum conditions, 95% of beef tallow, in 2.5 h, was converted into @COMPOUND$ by using commercial @PROTEIN$ SDL 451.	1
80	Lower expression of IGFBP1 and @PROTEIN$ mRNA and protein was observed in hESF from women with vs. those without endometriosis in response to @COMPOUND$, but not P4, suggesting a blunted response of these decidual biomarkers to activation of the PKA pathway in eutopic endometrium in women with disease.	1
81	Lower expression of @PROTEIN$ and prolactin mRNA and protein was observed in hESF from women with vs. those without endometriosis in response to @COMPOUND$, but not P4, suggesting a blunted response of these decidual biomarkers to activation of the PKA pathway in eutopic endometrium in women with disease.	1
82	Some of the peptide derivatives inhibited @PROTEIN$-mediated uptake of ((3)H) @COMPOUND$-Sar.	1
83	We report that the PP inhibition of proteolysis in young rats was mediated by the increased @PROTEIN$ secretion and resulted from a down-regulation of both lysosomal and @COMPOUND$+)-dependent proteolysis.	0
84	@COMPOUND$ induces apoptosis in colorectal carcinoma cells by modulating the @PROTEIN$ and p38 MAPK pathways.	1
85	@COMPOUND$ induces apoptosis in colorectal carcinoma cells by modulating the PI3 kinase and @PROTEIN$ pathways.	1
86	The protein inhibitors wortmannin (phosphoinositide 3 kinase inhibitor), PD 98059 (MEK inhibitor) and @COMPOUND$ (p38 inhibitor) as well as silencing RNA (small interfering RNA (siRNA)) of the @PROTEIN$ protein, were used to investigate cross-talk between signalling pathways.	0
87	The protein inhibitors wortmannin (@COMPOUND$ 3 kinase inhibitor), PD 98059 (MEK inhibitor) and SB 203580 (p38 inhibitor) as well as silencing RNA (small interfering RNA (siRNA)) of the @PROTEIN$ protein, were used to investigate cross-talk between signalling pathways.	0
88	The protein inhibitors @COMPOUND$ (phosphoinositide 3 kinase inhibitor), PD 98059 (MEK inhibitor) and SB 203580 (p38 inhibitor) as well as silencing RNA (small interfering RNA (siRNA)) of the @PROTEIN$ protein, were used to investigate cross-talk between signalling pathways.	0
89	The protein inhibitors wortmannin (phosphoinositide 3 kinase inhibitor), @COMPOUND$ (MEK inhibitor) and SB 203580 (p38 inhibitor) as well as silencing RNA (small interfering RNA (siRNA)) of the @PROTEIN$ protein, were used to investigate cross-talk between signalling pathways.	0
90	Chondrocytes grown in monolayer were treated with interleukin-1alpha (@PROTEIN$), insulin-like growth factor-I (IGF-I), C3 Transferase, @COMPOUND$, or transfected with Rho wild type or two constitutively active mutants of Rho (Q63L and G14V).	0
91	Chondrocytes grown in monolayer were treated with interleukin-1alpha (IL-1alpha), @PROTEIN$-like growth factor-I (IGF-I), C3 Transferase, @COMPOUND$, or transfected with Rho wild type or two constitutively active mutants of Rho (Q63L and G14V).	0
92	Chondrocytes grown in monolayer were treated with interleukin-1alpha (IL-1alpha), insulin-like growth factor-I (@PROTEIN$), C3 Transferase, @COMPOUND$, or transfected with Rho wild type or two constitutively active mutants of Rho (Q63L and G14V).	0
93	Affinity assays were performed to measure endogenous @COMPOUND$-bound @PROTEIN$, and confocal microscopy was used to assess changes in organization of the actin cytoskeleton.	1
94	Affinity assays were performed to measure endogenous @COMPOUND$-bound Rho, and confocal microscopy was used to assess changes in organization of the @PROTEIN$ cytoskeleton.	0
95	IL-1alpha and RhoG14V increased cytoplasmic @PROTEIN$ stress fiber formation, which was blocked by C3 Transferase, and @COMPOUND$.	1
96	@PROTEIN$ and RhoG14V increased cytoplasmic actin stress fiber formation, which was blocked by C3 Transferase, and @COMPOUND$.	1
97	Expression of RhoQ63L or RhoG14V resulted in increased MMP-13 expression; however, inhibition of Rho with @COMPOUND$ was unable to inhibit @PROTEIN$-induced MMP-13 expression.	0
98	Expression of @PROTEIN$Q63L or RhoG14V resulted in increased MMP-13 expression; however, inhibition of Rho with @COMPOUND$ was unable to inhibit IL-1alpha-induced MMP-13 expression.	1
99	Expression of RhoQ63L or RhoG14V resulted in increased @PROTEIN$ expression; however, inhibition of Rho with @COMPOUND$ was unable to inhibit IL-1alpha-induced MMP-13 expression.	0
100	@COMPOUND$ inhibits vasa vasorum neovascularization in aortas of @PROTEIN$ (-/-)/LDL(-/-) double knockout mice.	0
101	The central homeostasis is characterized by increased cerebrocortical synaptosomal T(3) content, deiodinase type II (@PROTEIN$) activity, and @COMPOUND$ content.	0
102	Validation of a food frequency questionnaire measurement of dietary acrylamide intake using @PROTEIN$ adducts of acrylamide and @COMPOUND$.	1
103	Our data indicate that genetic differences in @PROTEIN$ gene expression may predispose individual differences in the responsivity to repeated intake of @COMPOUND$.	1
104	17beta-Hydroxysteroid dehydrogenase type 1 (@PROTEIN$) is a key enzyme of @COMPOUND$ biosynthesis, which might play an important role in follicular development of the ovary.	1
105	@PROTEIN$ (HSD17B1) is a key enzyme of @COMPOUND$ biosynthesis, which might play an important role in follicular development of the ovary.	1
106	Because o-quinones are very unstable, we used an oxymetric method to characterize the kinetics of this substrate, based on measurements of the @COMPOUND$ consumed in the @PROTEIN$ reaction.	1
107	QSAR studies for the inhibition of the transmembrane @PROTEIN$ isozyme XIV with @COMPOUND$ using PRECLAV software.	1
108	QSAR studies for the inhibition of isozyme XIV of human @PROTEIN$ (CA, EC 4.2.1.1) by a series of @COMPOUND$ including clinically used derivatives (acetazolamide, methazolamide, ethoxzolamide, dichlorophenamide, dorzolamide, brinzolamide, benzolamide, and zonisamide) are presented.	1
109	Preprandial concentrations of glucose, @PROTEIN$, @COMPOUND$, and IGF-I fluctuated over time without significant treatment effect.	0
110	Preprandial concentrations of @COMPOUND$, NEFA, lactate, and @PROTEIN$ fluctuated over time without significant treatment effect.	0
111	Preprandial concentrations of glucose, NEFA, @COMPOUND$, and @PROTEIN$ fluctuated over time without significant treatment effect.	0
112	Preprandial concentrations of @COMPOUND$, @PROTEIN$, lactate, and IGF-I fluctuated over time without significant treatment effect.	0
113	In late gestation, the postprandial increases in @COMPOUND$ and @PROTEIN$ were delayed, and smaller, after a high-fiber meal than after a control meal.	0
114	During lactation, @COMPOUND$ and @PROTEIN$ profiles after a standard meal did not differ between sows from treatment groups.	0
115	Whereas their toxicity is due to @PROTEIN$ inhibition, their secondary toxic effects have been related to free @COMPOUND$ radicals.	0
116	@COMPOUND$ diminished the plasma @PROTEIN$ activity on day 1 post-treatment, although testosterone levels remained unaffected.	1
117	Diazinon diminished the plasma @PROTEIN$ activity on day 1 post-treatment, although @COMPOUND$ levels remained unaffected.	0
118	Melatonin pretreatment prevented every alteration induced by @COMPOUND$, except the diminution of @PROTEIN$ plasmatic activity.	1
119	@COMPOUND$ pretreatment prevented every alteration induced by diazinon, except the diminution of @PROTEIN$ plasmatic activity.	0
120	Differential gene expression of @PROTEIN$ and interleukin-1 receptor associated kinase-M in peripheral blood mononuclear cells of young and aged rats following preconditioning with @COMPOUND$.	1
121	The IL-1 receptor-associated kinase 1 (IRAK-1) and @PROTEIN$ are key signaling molecules in cellular responses to @COMPOUND$ initiated through the Toll-like receptors (TLRs).	1
122	The IL-1 receptor-associated kinase 1 (IRAK-1) and IRAK-M are key signaling molecules in cellular responses to @COMPOUND$ initiated through the Toll-like receptors (@PROTEIN$).	1
123	The IL-1 receptor-associated kinase 1 (@PROTEIN$) and IRAK-M are key signaling molecules in cellular responses to @COMPOUND$ initiated through the Toll-like receptors (TLRs).	1
124	The aim of this study was to evaluate the effect of age on the modulation of TLRs and IRAK-1 and @PROTEIN$ in peripheral blood mononuclear cells (PBMCs) exposed in vitro to @COMPOUND$ under conditions that could induce endotoxin tolerance.	0
125	The aim of this study was to evaluate the effect of age on the modulation of TLRs and @PROTEIN$ and IRAK-M in peripheral blood mononuclear cells (PBMCs) exposed in vitro to @COMPOUND$ under conditions that could induce endotoxin tolerance.	0
126	The aim of this study was to evaluate the effect of age on the modulation of @PROTEIN$ and IRAK-1 and IRAK-M in peripheral blood mononuclear cells (PBMCs) exposed in vitro to @COMPOUND$ under conditions that could induce endotoxin tolerance.	0
127	) production increased; metallothionein (MT) and @COMPOUND$ levels increased in most cases, and acetylcholinesterase (@PROTEIN$) activity decreased in summer.	0
128	) production increased; metallothionein (MT) and @COMPOUND$ levels increased in most cases, and @PROTEIN$ (AChE) activity decreased in summer.	0
129	Two principal signaling pathways that regulate proliferation are PI3K/@COMPOUND$/Akt and @PROTEIN$/Ras/ERK1/2.	0
130	Two principal signaling pathways that regulate proliferation are PI3K/@COMPOUND$/Akt and Shc/@PROTEIN$/ERK1/2.	0
131	Two principal signaling pathways that regulate proliferation are @PROTEIN$/@COMPOUND$/Akt and Shc/Ras/ERK1/2.	1
132	Two principal signaling pathways that regulate proliferation are PI3K/@COMPOUND$/@PROTEIN$ and Shc/Ras/ERK1/2.	1
133	Two principal signaling pathways that regulate proliferation are PI3K/@COMPOUND$/Akt and Shc/Ras/@PROTEIN$/2.	0
134	In this study we investigated the superoxide radicals scavenging effect and @PROTEIN$ inhibitory activity by @COMPOUND$, which was originally isolated from the roots of Salvia miltiorrhiza (also named Danshen or Dansham), an important herb in Oriental medicine.	1
135	In this study we investigated the @COMPOUND$ radicals scavenging effect and @PROTEIN$ inhibitory activity by magnesium lithospermate B, which was originally isolated from the roots of Salvia miltiorrhiza (also named Danshen or Dansham), an important herb in Oriental medicine.	0
136	Superoxide radicals were generated both in beta-NADH/@COMPOUND$ system and xanthine/@PROTEIN$ system.	0
137	Superoxide radicals were generated both in @COMPOUND$/PMS system and xanthine/@PROTEIN$ system.	0
138	Superoxide radicals were generated both in beta-NADH/PMS system and @COMPOUND$/@PROTEIN$ system.	1
139	@COMPOUND$ radicals were generated both in beta-NADH/PMS system and xanthine/@PROTEIN$ system.	1
140	Further study suggested that @COMPOUND$ can directly inhibit @PROTEIN$ and exhibits competitive inhibition.	1
141	In addition, @COMPOUND$ significantly protected HL-60 cells from superoxide radicals-induced apoptosis in the xanthine/@PROTEIN$ reactions.	1
142	In addition, magnesium lithospermate B significantly protected HL-60 cells from superoxide radicals-induced apoptosis in the @COMPOUND$/@PROTEIN$ reactions.	1
143	Concentrations of @COMPOUND$, @PROTEIN$, C-peptide, nonesterified fatty acids, triacylglycerol, total and exogenous glucose kinetics were assessed for 6 h postprandially.	0
144	After 120 min, @COMPOUND$ and @PROTEIN$ responses declined, but remained higher after the Pol 0.05) in parallel to the inhibition of lipolysis.	0
145	The objective of the present study was to investigate the effects of a high-@COMPOUND$ diet on @PROTEIN$ expression and IR localization and activity in the rat liver.	1
146	Intravenous @COMPOUND$ enhances @PROTEIN$ activity giving cardioprotection.	1
147	We investigated whether acute intravenous @COMPOUND$, through an effect on cyclooxygenase (COX)-2 and heat shock protein (@PROTEIN$) 72, might induce preconditioning.	1
148	We investigated whether acute intravenous @COMPOUND$, through an effect on cyclooxygenase (@PROTEIN$)-2 and heat shock protein (HSP) 72, might induce preconditioning.	1
149	Exposure to @COMPOUND$ for 6 h induced expression of both caveolin-1 and cyclooxygenase (@PROTEIN$)-2.	1
150	Exposure to @COMPOUND$ for 6 h induced expression of both @PROTEIN$ and cyclooxygenase (COX)-2.	1
151	Pretreatment with @COMPOUND$ blocked fatty-acid-induced @PROTEIN$ and COX-2 expression in a time- and concentration-dependent manner.	1
152	Pretreatment with @COMPOUND$ blocked fatty-acid-induced caveolin-1 and @PROTEIN$ expression in a time- and concentration-dependent manner.	1
153	Exposure to @COMPOUND$ rapidly increased phosphorylation of several kinases, including @PROTEIN$, extracellular signal regulated kinase 1/2 (ERK1/2) and amino kinase terminal (Akt), with maximal induction at about 10 min.	1
154	Exposure to @COMPOUND$ rapidly increased phosphorylation of several kinases, including p38 MAPK, extracellular signal regulated kinase 1/2 (ERK1/2) and amino kinase terminal (@PROTEIN$), with maximal induction at about 10 min.	1
155	Exposure to @COMPOUND$ rapidly increased phosphorylation of several kinases, including p38 MAPK, @PROTEIN$/2 (ERK1/2) and amino kinase terminal (Akt), with maximal induction at about 10 min.	1
156	Exposure to @COMPOUND$ rapidly increased phosphorylation of several kinases, including p38 MAPK, extracellular signal regulated kinase 1/2 (@PROTEIN$/2) and amino kinase terminal (Akt), with maximal induction at about 10 min.	1
157	Inhibitors of ERK1/2 and Akt down-regulated the @COMPOUND$-induced increase in @PROTEIN$ protein, which also occurred after pretreatment with EGCG.	1
158	Inhibitors of ERK1/2 and Akt down-regulated the linoleic-acid-induced increase in @PROTEIN$ protein, which also occurred after pretreatment with @COMPOUND$.	1
159	Caveolin-1 silencing blocked @COMPOUND$-induced phosphorylation of @PROTEIN$/2 and protein expression of COX-2, suggesting that specific MAPK signaling is caveolae dependent.	1
160	@PROTEIN$ silencing blocked @COMPOUND$-induced phosphorylation of ERK1/2 and protein expression of COX-2, suggesting that specific MAPK signaling is caveolae dependent.	0
161	Caveolin-1 silencing blocked @COMPOUND$-induced phosphorylation of ERK1/2 and protein expression of COX-2, suggesting that specific @PROTEIN$ signaling is caveolae dependent.	1
162	Caveolin-1 silencing blocked @COMPOUND$-induced phosphorylation of ERK1/2 and protein expression of @PROTEIN$, suggesting that specific MAPK signaling is caveolae dependent.	1
163	Here we report the docking study of four @COMPOUND$ catechins and four alkylating anticancer drugs into the @PROTEIN$ model, as GSTs were found to be affected by tea catechins.	1
164	Here we report the docking study of four @COMPOUND$ catechins and four alkylating anticancer drugs into the GST P1-1 model, as @PROTEIN$ were found to be affected by tea catechins.	1
165	Leptin and soluble @PROTEIN$ receptor changes after pulmonary endarterectomy: relations to @COMPOUND$ and cytokine network.	1
166	@PROTEIN$ and soluble leptin receptor changes after pulmonary endarterectomy: relations to @COMPOUND$ and cytokine network.	1
167	Leptin and soluble @PROTEIN$ receptor (SLR) were compared with evolution of @COMPOUND$ and inflammatory cytokines in twenty-two patients with chronic thromboembolic pulmonary hypertension treated with pulmonary endarterectomy using cardiopulmonary bypass (CBP) and deep hypothermic circulatory arrest (DHCA).	0
168	@PROTEIN$ and soluble leptin receptor (SLR) were compared with evolution of @COMPOUND$ and inflammatory cytokines in twenty-two patients with chronic thromboembolic pulmonary hypertension treated with pulmonary endarterectomy using cardiopulmonary bypass (CBP) and deep hypothermic circulatory arrest (DHCA).	0
169	In the present work, the activity of the enzymes xylose reductase (XR); @COMPOUND$ dehydrogenase (XD); and glucose-6-phosphate dehydrogenase (@PROTEIN$) during cultivation of Candida guilliermondii on rice straw hemicellulosic hydrolysate was measured and correlated with xylitol production under different pH values (around 4.5 and 7.5) and initial xylose concentration (around 30 and 70 g l(-1)).	1
170	In the present work, the activity of the enzymes @PROTEIN$ (XR); @COMPOUND$ dehydrogenase (XD); and glucose-6-phosphate dehydrogenase (G6PD) during cultivation of Candida guilliermondii on rice straw hemicellulosic hydrolysate was measured and correlated with xylitol production under different pH values (around 4.5 and 7.5) and initial xylose concentration (around 30 and 70 g l(-1)).	1
171	Pregnant Sprague-Dawley female rats were treated once with @COMPOUND$ (0, 0.3 or 1 microg/kg) by gavage on embryonic day (ED) 11 and the expression levels of androgen (AR) and @PROTEIN$ (ER), steroidogenic enzymes (P450scc and 3beta-HSD) and four regulatory factors (StAR, SF-1, GATA-4 and Insl-3) involved in foetal Leydig cell and adrenal function were analysed on ED 19.5.	0
172	Pregnant Sprague-Dawley female rats were treated once with @COMPOUND$ (0, 0.3 or 1 microg/kg) by gavage on embryonic day (ED) 11 and the expression levels of androgen (AR) and estrogen receptors (ER), steroidogenic enzymes (P450scc and 3beta-HSD) and four regulatory factors (StAR, @PROTEIN$, GATA-4 and Insl-3) involved in foetal Leydig cell and adrenal function were analysed on ED 19.5.	0
173	Pregnant Sprague-Dawley female rats were treated once with @COMPOUND$ (0, 0.3 or 1 microg/kg) by gavage on embryonic day (ED) 11 and the expression levels of androgen (AR) and estrogen receptors (ER), steroidogenic enzymes (P450scc and @PROTEIN$) and four regulatory factors (StAR, SF-1, GATA-4 and Insl-3) involved in foetal Leydig cell and adrenal function were analysed on ED 19.5.	0
174	Pregnant Sprague-Dawley female rats were treated once with @COMPOUND$ (0, 0.3 or 1 microg/kg) by gavage on embryonic day (ED) 11 and the expression levels of androgen (AR) and estrogen receptors (ER), steroidogenic enzymes (P450scc and 3beta-HSD) and four regulatory factors (StAR, SF-1, @PROTEIN$-4 and Insl-3) involved in foetal Leydig cell and adrenal function were analysed on ED 19.5.	0
175	Pregnant Sprague-Dawley female rats were treated once with @COMPOUND$ (0, 0.3 or 1 microg/kg) by gavage on embryonic day (ED) 11 and the expression levels of androgen (AR) and estrogen receptors (ER), steroidogenic enzymes (P450scc and 3beta-HSD) and four regulatory factors (@PROTEIN$, SF-1, GATA-4 and Insl-3) involved in foetal Leydig cell and adrenal function were analysed on ED 19.5.	0
176	In utero exposure to @COMPOUND$ reduced intratesticular T of foetal males (significant at 0.3 microg/kg TCDD) and tended to reduce the protein expression of @PROTEIN$ and AR of foetal male rat testis.	1
177	mRNA expression of developmental regulatory factors was not influenced by foetal @COMPOUND$ exposure, except for significantly reduced adrenal @PROTEIN$.	1
178	Lastly, we found that the downstream metabolite of @COMPOUND$, 5alpha- androstane-3beta,17beta-diol (3betaAdiol), is estrogenic in breast cancer cells, and induces growth and ER-signaling via activation of @PROTEIN$.	1
179	@COMPOUND$ inhibited tumor growth in a manner independent of dose and inhibited phosphorylation of @PROTEIN$ and paxillin in a dose-dependent manner in a Calu-6 xenograft model.	1
180	@COMPOUND$ inhibited tumor growth in a manner independent of dose and inhibited phosphorylation of FAK and @PROTEIN$ in a dose-dependent manner in a Calu-6 xenograft model.	1
181	With the exception of significantly elevated serum @PROTEIN$ after @COMPOUND$, no effects in the secondary outcome measures were detected.	1
182	@PROTEIN$ expression analysis in chemotherapy-naive patients with advanced non-small-cell lung cancer treated with gefitinib or placebo in combination with @COMPOUND$-based chemotherapy.	1
183	Moreover, diacylgycerol-dependent protein kinase C isoenzymes and activation of extracellular signal-regulated protein kinase (@PROTEIN$) are required for glucose-, @COMPOUND$- and KCl-induced Egr-1 expression.	1
184	Moreover, diacylgycerol-dependent @PROTEIN$ isoenzymes and activation of extracellular signal-regulated protein kinase (ERK) are required for @COMPOUND$-, tolbutamide- and KCl-induced Egr-1 expression.	1
185	Moreover, diacylgycerol-dependent @PROTEIN$ isoenzymes and activation of extracellular signal-regulated protein kinase (ERK) are required for glucose-, @COMPOUND$- and KCl-induced Egr-1 expression.	1
186	Moreover, diacylgycerol-dependent protein kinase C isoenzymes and activation of extracellular signal-regulated protein kinase (ERK) are required for glucose-, @COMPOUND$- and KCl-induced @PROTEIN$ expression.	1
187	Moreover, diacylgycerol-dependent protein kinase C isoenzymes and activation of extracellular signal-regulated protein kinase (ERK) are required for @COMPOUND$-, tolbutamide- and KCl-induced @PROTEIN$ expression.	1
188	Moreover, diacylgycerol-dependent protein kinase C isoenzymes and activation of extracellular signal-regulated protein kinase (@PROTEIN$) are required for @COMPOUND$-, tolbutamide- and KCl-induced Egr-1 expression.	1
189	Moreover, diacylgycerol-dependent @PROTEIN$ C isoenzymes and activation of extracellular signal-regulated protein kinase (ERK) are required for @COMPOUND$-, tolbutamide- and KCl-induced Egr-1 expression.	1
190	Moreover, diacylgycerol-dependent @PROTEIN$ C isoenzymes and activation of extracellular signal-regulated protein kinase (ERK) are required for glucose-, @COMPOUND$- and KCl-induced Egr-1 expression.	1
191	Patients under clozapine-@COMPOUND$ therapy developed a rise of serum @PROTEIN$ levels.	1
192	Patients under @COMPOUND$-risperidone therapy developed a rise of serum @PROTEIN$ levels.	1
193	@PROTEIN$ receptor-1 is essential for LPS-induced sensitization and tolerance to @COMPOUND$-glucose deprivation in murine neonatal organotypic hippocampal slices.	1
194	@PROTEIN$ receptor-1 is essential for LPS-induced sensitization and tolerance to oxygen-@COMPOUND$ deprivation in murine neonatal organotypic hippocampal slices.	1
195	The role of tumor necrosis factor (@PROTEIN$) receptors 1 and 2 in @COMPOUND$ (LPS)-induced sensitization and tolerance to oxygen-glucose deprivation (OGD) was evaluated in neonatal murine hippocampal organotypic slices.	1
196	The role of @PROTEIN$ (TNF) receptors 1 and 2 in @COMPOUND$ (LPS)-induced sensitization and tolerance to oxygen-glucose deprivation (OGD) was evaluated in neonatal murine hippocampal organotypic slices.	1
197	Association between @COMPOUND$ (247) polymorphism of @PROTEIN$ and cerebral infarction in a Chinese population.	1
198	The purpose of this study was to identify associations between the @COMPOUND$ (247) polymorphism of @PROTEIN$ gene and CI in a Chinese cohort.	1
199	Our study demonstrates that @COMPOUND$ causes evident damage to acinar cells, impairing both calcium homeostasis and secretory response to @PROTEIN$.	1
200	Recent studies suggest that crystals of monosodium urate (MSU), deposited in joints of patients with acute gouty arthritis, activate the NACHT domain, @COMPOUND$-rich repeat and @PROTEIN$ domain-containing protein (NALP)3 inflammasome.	0
201	Recent studies suggest that crystals of @COMPOUND$ (MSU), deposited in joints of patients with acute gouty arthritis, activate the NACHT domain, leucine-rich repeat and @PROTEIN$ domain-containing protein (NALP)3 inflammasome.	1
202	LDL from all subjects stimulated both the basal and @PROTEIN$-induced @COMPOUND$ and cortisol release from adrenocortical cells.	1
203	LDL from all subjects stimulated both the basal and @PROTEIN$-induced aldosterone and @COMPOUND$ release from adrenocortical cells.	1
204	It was found from this group that @COMPOUND$ was the best alternative to warfarin for examining the interactions of drugs at Sudlow site I on @PROTEIN$.	1
205	This review provides an introduction to epigenetic concepts for renal investigators and an overview of our work detailing an epigenetic pathway for @COMPOUND$ signaling and the control of epithelial @PROTEIN$-alpha (ENaCalpha) subunit gene expression in the collecting duct.	0
206	A series of novel bis-pyridinium oximes connected by bis-@COMPOUND$, 1,4-bis-methoxymethyl (cis)-but-2-ene and 1,4-bis-methoxymethyl but-2-yne linkers were synthesized and their in vitro reactivation efficacy was evaluated against diisopropyl phosphorofluoridate (DFP) inhibited @PROTEIN$ (AChE) and compared with the established antidote 2-PAM and obidoxime.	0
207	A series of novel bis-pyridinium oximes connected by bis-@COMPOUND$, 1,4-bis-methoxymethyl (cis)-but-2-ene and 1,4-bis-methoxymethyl but-2-yne linkers were synthesized and their in vitro reactivation efficacy was evaluated against diisopropyl phosphorofluoridate (DFP) inhibited acetylcholinesterase (@PROTEIN$) and compared with the established antidote 2-PAM and obidoxime.	0
208	A series of novel bis-pyridinium oximes connected by bis-methoxymethyl benzene, 1,4-bis-methoxymethyl (cis)-but-2-ene and 1,4-bis-methoxymethyl but-2-yne linkers were synthesized and their in vitro reactivation efficacy was evaluated against @COMPOUND$ (DFP) inhibited acetylcholinesterase (@PROTEIN$) and compared with the established antidote 2-PAM and obidoxime.	0
209	A series of novel bis-pyridinium oximes connected by bis-methoxymethyl benzene, 1,4-bis-methoxymethyl (cis)-but-2-ene and 1,4-bis-methoxymethyl but-2-yne linkers were synthesized and their in vitro reactivation efficacy was evaluated against diisopropyl phosphorofluoridate (DFP) inhibited @PROTEIN$ (AChE) and compared with the established antidote 2-PAM and @COMPOUND$.	0
210	A series of novel bis-pyridinium oximes connected by bis-methoxymethyl benzene, 1,4-bis-methoxymethyl (cis)-but-2-ene and 1,4-bis-methoxymethyl but-2-yne linkers were synthesized and their in vitro reactivation efficacy was evaluated against diisopropyl phosphorofluoridate (DFP) inhibited acetylcholinesterase (@PROTEIN$) and compared with the established antidote 2-PAM and @COMPOUND$.	0
211	A series of novel bis-pyridinium oximes connected by bis-methoxymethyl benzene, 1,4-bis-methoxymethyl (cis)-but-2-ene and 1,4-bis-methoxymethyl but-2-yne linkers were synthesized and their in vitro reactivation efficacy was evaluated against @COMPOUND$ (DFP) inhibited @PROTEIN$ (AChE) and compared with the established antidote 2-PAM and obidoxime.	0
212	In search for the pharmacophore and to analyze structure-activity relationships we synthesized a series of truncated derivatives and analogs of RB-2, including 1-amino-2-sulfo-4-ar(alk)ylaminoanthraquinones, 1-amino-2-methyl-4-arylaminoanthraquinones, @COMPOUND$ esters and sulfonamides, and bis-(1-amino-4-bromoanthraquinone) sulfonamides, and investigated them in preparations of rat @PROTEIN$, 2, and 3 using a capillary electrophoresis assay.	0
213	In search for the pharmacophore and to analyze structure-activity relationships we synthesized a series of truncated derivatives and analogs of @COMPOUND$, including 1-amino-2-sulfo-4-ar(alk)ylaminoanthraquinones, 1-amino-2-methyl-4-arylaminoanthraquinones, 1-amino-4-bromoanthraquinone 2-sulfonic acid esters and sulfonamides, and bis-(1-amino-4-bromoanthraquinone) sulfonamides, and investigated them in preparations of rat @PROTEIN$, 2, and 3 using a capillary electrophoresis assay.	0
214	This signaling system is engaged by the active component of cannabis, Delta9-tetrahydrocannabinol (@COMPOUND$), which exerts its pharmacological effects by activation of G protein-coupled type-1 (CB1) and type-2 (@PROTEIN$) cannabinoid receptors.	1
215	This signaling system is engaged by the active component of cannabis, @COMPOUND$ (Delta9-THC), which exerts its pharmacological effects by activation of G protein-coupled type-1 (CB1) and type-2 (@PROTEIN$) cannabinoid receptors.	1
216	This signaling system is engaged by the active component of cannabis, @COMPOUND$ (Delta9-THC), which exerts its pharmacological effects by activation of G protein-coupled type-1 (@PROTEIN$) and type-2 (CB2) cannabinoid receptors.	1
217	This signaling system is engaged by the active component of cannabis, Delta9-tetrahydrocannabinol (@COMPOUND$), which exerts its pharmacological effects by activation of G protein-coupled type-1 (@PROTEIN$) and type-2 (CB2) cannabinoid receptors.	1
218	Since biliverdin and @COMPOUND$ are downstream products of heme degradation by @PROTEIN$ (HO), it has been suggested that HO-activity protects against curcumin-induced apoptosis.	1
219	Since biliverdin and bilirubin are downstream products of @COMPOUND$ degradation by @PROTEIN$ (HO), it has been suggested that HO-activity protects against curcumin-induced apoptosis.	0
220	Since @COMPOUND$ and bilirubin are downstream products of heme degradation by @PROTEIN$ (HO), it has been suggested that HO-activity protects against curcumin-induced apoptosis.	1
221	In the present study we determined the effect of @PROTEIN$ on the secretome by comparing incorporation rates of (13)C-labeled @COMPOUND$ in the presence and absence of insulin.	0
222	We determined the plasma concentrations of tryptophan (TRP), @COMPOUND$, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn @PROTEIN$ (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
223	We determined the plasma concentrations of @COMPOUND$ (TRP), KYN, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn @PROTEIN$) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
224	We determined the plasma concentrations of @COMPOUND$ (TRP), KYN, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn @PROTEIN$ (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
225	We determined the plasma concentrations of tryptophan (TRP), @COMPOUND$, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs @PROTEIN$) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
226	We determined the plasma concentrations of tryptophan (TRP), KYN, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn su@COMPOUND$ dismutase (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs @PROTEIN$) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
227	We determined the plasma concentrations of tryptophan (TRP), KYN, @COMPOUND$ (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn @PROTEIN$) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
228	We determined the plasma concentrations of tryptophan (TRP), @COMPOUND$, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn @PROTEIN$) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
229	We determined the plasma concentrations of tryptophan (TRP), KYN, @COMPOUND$ (3-HKYN); two distinct SOX markers: Cu/Zn @PROTEIN$ (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
230	We determined the plasma concentrations of @COMPOUND$ (TRP), KYN, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs @PROTEIN$) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
231	We determined the plasma concentrations of tryptophan (TRP), KYN, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn su@COMPOUND$ dismutase (Cu/Zn @PROTEIN$) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
232	We determined the plasma concentrations of tryptophan (TRP), KYN, @COMPOUND$ (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs @PROTEIN$) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
233	ESRD patients showed a significant increase in Cu/Zn @PROTEIN$, total @COMPOUND$ and hs CRP levels between controls and all patients group.	0
234	ESRD patients showed a significant increase in Cu/Zn SOD, total @COMPOUND$ and hs @PROTEIN$ levels between controls and all patients group.	0
235	@PROTEIN$ (UDP-N-acetylmuramoyl-L-alanine:D-glutamate ligase), a three-domain bacterial protein, catalyses a highly specific incorporation of D-glutamate to the cytoplasmic intermediate UDP-N-acetyl-muramoyl-L-alanine (@COMPOUND$) utilizing ATP hydrolysis to ADP and P(i).	1
236	On the basis of structural studies of @PROTEIN$ complexes, a stepwise catalytic mechanism was proposed that commences with a formation of the acyl-phosphate intermediate, followed by a nucleophilic attack of @COMPOUND$ that, through the formation of a tetrahedral reaction intermediate and subsequent phosphate dissociation, affords the final product, UDP-N-acetyl-muramoyl-L-alanine-D-glutamate (UMAG).	1
237	Glutathione S-transferases (@PROTEIN$) are multifunctional phase II detoxification enzymes that catalyze the attachment of electrophilic substrates to @COMPOUND$.	1
238	@PROTEIN$ (GSTs) are multifunctional phase II detoxification enzymes that catalyze the attachment of electrophilic substrates to @COMPOUND$.	1
239	Bacterial strains differed in their ability to synthesize @COMPOUND$ and hydrogen cyanide compounds, as well as in their @PROTEIN$ activity.	0
240	Bacterial strains differed in their ability to synthesize auxin and @COMPOUND$ compounds, as well as in their @PROTEIN$ activity.	0
241	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, catalase, @PROTEIN$, superoxide dismutase and the concentration of nitric oxide, @COMPOUND$ and glutathione increased.	0
242	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, catalase, @PROTEIN$, superoxide dismutase and the concentration of @COMPOUND$, ascorbic acid and glutathione increased.	0
243	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, @PROTEIN$, peroxidase, superoxide dismutase and the concentration of nitric oxide, @COMPOUND$ and glutathione increased.	0
244	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, catalase, peroxidase, @PROTEIN$ and the concentration of @COMPOUND$, ascorbic acid and glutathione increased.	0
245	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, @PROTEIN$, peroxidase, superoxide dismutase and the concentration of @COMPOUND$, ascorbic acid and glutathione increased.	0
246	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of @PROTEIN$, catalase, peroxidase, superoxide dismutase and the concentration of nitric oxide, @COMPOUND$ and glutathione increased.	0
247	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of @PROTEIN$, catalase, peroxidase, superoxide dismutase and the concentration of nitric oxide, ascorbic acid and @COMPOUND$ increased.	0
248	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, catalase, peroxidase, @PROTEIN$ and the concentration of nitric oxide, @COMPOUND$ and glutathione increased.	0
249	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, catalase, peroxidase, @PROTEIN$ and the concentration of nitric oxide, ascorbic acid and @COMPOUND$ increased.	0
250	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, catalase, @PROTEIN$, superoxide dismutase and the concentration of nitric oxide, ascorbic acid and @COMPOUND$ increased.	0
251	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of @PROTEIN$, catalase, peroxidase, superoxide dismutase and the concentration of @COMPOUND$, ascorbic acid and glutathione increased.	0
252	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of nitricoxide synthase, @PROTEIN$, peroxidase, superoxide dismutase and the concentration of nitric oxide, ascorbic acid and @COMPOUND$ increased.	0
253	It is a serious problem that effective treatment choices to T315I, in the @PROTEIN$ kinase domain that shows a strong tolerance in @COMPOUND$ do not exist clinically.	1
254	Cell viability and reactive oxygen species concentration were determined, and the effects of pre-treatment with LA on these parameters were investigated together with the @PROTEIN$ and GPx activity as well as the concentration of @COMPOUND$.	0
255	Cell viability and reactive @COMPOUND$ species concentration were determined, and the effects of pre-treatment with LA on these parameters were investigated together with the @PROTEIN$ and GPx activity as well as the concentration of reduced glutathione.	0
256	Reactivity of @COMPOUND$ with the (4Fe-4S) cluster of @PROTEIN$ from Escherichia coli.	1
257	The rate constant for the initial reaction between NO and the @PROTEIN$ (@COMPOUND$ is estimated to be (7.0+/-2.0)x10(6) M(-2) x s(-1) at 25 degrees C, which is approx.	1
258	As one of the very few repair systems for oxidized proteins, @PROTEIN$ and MsrB enzymes play a major role in protein homeostasis during aging and have also been involved in cellular defenses against oxidative stress, by scavenging reactive @COMPOUND$ species.	1
259	As one of the very few repair systems for oxidized proteins, MsrA and @PROTEIN$ enzymes play a major role in protein homeostasis during aging and have also been involved in cellular defenses against oxidative stress, by scavenging reactive @COMPOUND$ species.	1
260	Effect of short-time exposures to @COMPOUND$ and lead on brain @PROTEIN$ from Danio rerio and Poecilia reticulata.	1
261	The aim of this work was to verify, in two small size freshwater teleosts Danio rerio and Poecilia reticulata, the effects of short-time exposures (24 and 72 h) to a sublethal dose (500 microg/L) of @COMPOUND$ and lead, on brain monoamine oxidase (@PROTEIN$), an important neural enzyme.	1
262	The aim of this work was to verify, in two small size freshwater teleosts Danio rerio and Poecilia reticulata, the effects of short-time exposures (24 and 72 h) to a sublethal dose (500 microg/L) of @COMPOUND$ and lead, on brain @PROTEIN$ (MAO), an important neural enzyme.	1
263	@PROTEIN$ is also important in the regulation of @COMPOUND$ signaling, a second messenger implicated in learning, memory, and mood.	1
264	@PROTEIN$ 13910 CC genotype is associated with @COMPOUND$ intolerance, a condition often resulting in reduced milk intake.	1
265	@COMPOUND$-induced survival was a rapid event that was accompanied by early and sustained activation of major survival signaling proteins, such as AKT/phosphatidylinositol 3-kinase and extracellular-regulated kinase (activated from 5 min to 18 h), as well as protein kinase C (PKC)-alpha (30 min to 18 h), in concert with unaltered c-@PROTEIN$ N-amino terminal kinase levels and early inactivation of key death-related signals like PKC-delta (5 min to 18 h).	1
266	@COMPOUND$-induced survival was a rapid event that was accompanied by early and sustained activation of major survival signaling proteins, such as AKT/phosphatidylinositol 3-kinase and extracellular-regulated kinase (activated from 5 min to 18 h), as well as protein kinase C (@PROTEIN$)-alpha (30 min to 18 h), in concert with unaltered c-jun N-amino terminal kinase levels and early inactivation of key death-related signals like PKC-delta (5 min to 18 h).	1
267	@COMPOUND$-induced survival was a rapid event that was accompanied by early and sustained activation of major survival signaling proteins, such as AKT/phosphatidylinositol 3-kinase and extracellular-regulated kinase (activated from 5 min to 18 h), as well as protein kinase C (PKC)-alpha (30 min to 18 h), in concert with unaltered c-jun N-amino terminal kinase levels and early inactivation of key death-related signals like @PROTEIN$ (5 min to 18 h).	1
268	@COMPOUND$-induced survival was a rapid event that was accompanied by early and sustained activation of major survival signaling proteins, such as AKT/phosphatidylinositol 3-kinase and extracellular-regulated kinase (activated from 5 min to 18 h), as well as @PROTEIN$ (PKC)-alpha (30 min to 18 h), in concert with unaltered c-jun N-amino terminal kinase levels and early inactivation of key death-related signals like PKC-delta (5 min to 18 h).	1
269	@COMPOUND$ selectively causes Bax- and @PROTEIN$-mediated apoptosis in human lung cancer cells.	1
270	@COMPOUND$ selectively causes @PROTEIN$- and Bak-mediated apoptosis in human lung cancer cells.	1
271	The @COMPOUND$-mediated G2-M phase cell cycle arrest was explained by down-regulation of cyclin-dependent kinase 1 (@PROTEIN$) and cell division cycle 25C protein expression leading to accumulation of Tyr15 phosphorylated (inactive) Cdk1.	1
272	The @COMPOUND$-mediated G2-M phase cell cycle arrest was explained by down-regulation of @PROTEIN$ (Cdk1) and cell division cycle 25C protein expression leading to accumulation of Tyr15 phosphorylated (inactive) Cdk1.	1
273	Knockdown of Bax and @PROTEIN$ proteins conferred significant protection against @COMPOUND$-induced apoptotic cytoplasmic histone-associated DNA fragmentation.	0
274	Knockdown of @PROTEIN$ and Bak proteins conferred significant protection against @COMPOUND$-induced apoptotic cytoplasmic histone-associated DNA fragmentation.	0
275	@PROTEIN$ (Cox-2) is a key enzyme in the conversion of @COMPOUND$ to prostaglandins that has been shown to have a particular importance in the progression of several malignancies including nasopharyngeal carcinoma (NPC).	1
276	Cyclooxygenase-2 (@PROTEIN$) is a key enzyme in the conversion of @COMPOUND$ to prostaglandins that has been shown to have a particular importance in the progression of several malignancies including nasopharyngeal carcinoma (NPC).	1
277	However, in addition to @PROTEIN$ activity, we discovered that EGST also possesses @COMPOUND$ : disulfide oxidoreductase activity, for which the residue Cys (10) plays an essential role.	0
278	However, in addition to GST activity, we discovered that EGST also possesses @COMPOUND$ : @PROTEIN$ activity, for which the residue Cys (10) plays an essential role.	0
279	The mood stabilizers @COMPOUND$ and valproate selectively activate the promoter IV of @PROTEIN$ in neurons.	1
280	The mood stabilizers lithium and @COMPOUND$ selectively activate the promoter IV of @PROTEIN$ in neurons.	1
281	Treatment of cultured rat cortical neurons with therapeutic concentrations of @COMPOUND$ or VPA selectively increased the levels of exon IV (formerly rat exon III)-containing @PROTEIN$ mRNA, and the activity of BDNF promoter IV.	1
282	We showed that @COMPOUND$-induced activation of promoter IV was mimicked by pharmacological inhibition of GSK-3 or short interfering RNA (siRNA)-mediated gene silencing of @PROTEIN$ or GSK-3beta isoforms.	1
283	We showed that @COMPOUND$-induced activation of promoter IV was mimicked by pharmacological inhibition of GSK-3 or short interfering RNA (siRNA)-mediated gene silencing of GSK-3alpha or @PROTEIN$ isoforms.	1
284	We showed that @COMPOUND$-induced activation of promoter IV was mimicked by pharmacological inhibition of @PROTEIN$ or short interfering RNA (siRNA)-mediated gene silencing of GSK-3alpha or GSK-3beta isoforms.	1
285	Furthermore, treatment with other HDAC inhibitors, @COMPOUND$ and trichostatin A, or transfection with an HDAC1-specific siRNA also activated @PROTEIN$ promoter IV.	1
286	Furthermore, treatment with other HDAC inhibitors, sodium butyrate and @COMPOUND$, or transfection with an HDAC1-specific siRNA also activated @PROTEIN$ promoter IV.	1
287	Our study demonstrates for the first time that @PROTEIN$ and HDAC are respective initial targets for @COMPOUND$ and VPA to activate BDNF promoter IV, and that this BDNF induction involves a novel responsive region in promoter IV of the BDNF gene.	1
288	Our study demonstrates for the first time that GSK-3 and HDAC are respective initial targets for @COMPOUND$ and VPA to activate @PROTEIN$ promoter IV, and that this BDNF induction involves a novel responsive region in promoter IV of the BDNF gene.	0
289	@COMPOUND$, a new inhibitor of non-apoptotic death, rescued cells from death by @PROTEIN$, although the effect was also partial and temporary.	1
290	Despite their inhibitory effects on inflammatory gene expression, loss of @PROTEIN$ or LXRs in macrophages did not exert major effects on obesity or @COMPOUND$ tolerance induced by a high-fat diet.	0
291	Our results do not exclude a contribution of macrophage @PROTEIN$ and LXR expression to systemic metabolism in certain contexts, but these factors do not appear to be dominant contributors to @COMPOUND$ tolerance in a high-fat-fed Th1-biased bone marrow transplant model.	0
292	@PROTEIN$/Akt activity, analyzed by phosphatidylinositol trisphosphate production and phosphorylated Akt (p-Akt) expression, was higher in the resistant cell lines than in the sensitive one and inhibition with @COMPOUND$ or LY294002 improved apoptosis in the resistant cell lines.	1
293	@PROTEIN$/Akt activity, analyzed by phosphatidylinositol trisphosphate production and phosphorylated Akt (p-Akt) expression, was higher in the resistant cell lines than in the sensitive one and inhibition with wortmannin or @COMPOUND$ improved apoptosis in the resistant cell lines.	1
294	@PROTEIN$/Akt activity, analyzed by @COMPOUND$ trisphosphate production and phosphorylated Akt (p-Akt) expression, was higher in the resistant cell lines than in the sensitive one and inhibition with wortmannin or LY294002 improved apoptosis in the resistant cell lines.	1
295	Vincristine but not @COMPOUND$ increased p-@PROTEIN$ expression whereas co-treatment with PI3K inhibitors and vincristine increased apoptosis in the three cell lines.	0
296	@COMPOUND$ but not doxorubicin increased p-@PROTEIN$ expression whereas co-treatment with PI3K inhibitors and vincristine increased apoptosis in the three cell lines.	1
297	Vincristine but not doxorubicin increased p-@PROTEIN$ expression whereas co-treatment with PI3K inhibitors and @COMPOUND$ increased apoptosis in the three cell lines.	0
298	Wortmannin and @COMPOUND$ inhibited P-@PROTEIN$ (Pgp) function and also increased NF-kappaB activity.	1
299	@COMPOUND$ and LY294002 inhibited P-@PROTEIN$ (Pgp) function and also increased NF-kappaB activity.	1
300	Decreased @PROTEIN$ expression increases extracellular @COMPOUND$ and alters its regulation in mouse striatum.	1
301	Plasma @PROTEIN$ 0.05) following ingestion of GluF than after Glu alone, without any differences between the effects of either intervention on plasma @COMPOUND$ concentrations.	0
302	Immunofluorescence microscopy of live human umbilical vein endothelial cells showed that @PROTEIN$ multimers rapidly formed strings several hundred micrometers long on the cell surface after stimulation with @COMPOUND$.	1
303	Soluble P-selectin reduced the number of platelet-decorated @PROTEIN$ strings in the absence of @COMPOUND$+) and Mg(2+) but had no effect in the presence of these cations.	1
304	The present investigation was carried out to assess the erythrocytic oxidative stress indices such as lipid peroxides level and activities of antioxidant enzymes such as @PROTEIN$ and catalase, and some hematological parameters after treatment of subclinically ketotic lactating cows with antioxidants, @COMPOUND$ and selenium, incorporated in conventional treatment regimen.	0
305	The present investigation was carried out to assess the erythrocytic oxidative stress indices such as lipid peroxides level and activities of antioxidant enzymes such as superoxide dismutase and @PROTEIN$, and some hematological parameters after treatment of subclinically ketotic lactating cows with antioxidants, @COMPOUND$ and selenium, incorporated in conventional treatment regimen.	0
306	The present investigation was carried out to assess the erythrocytic oxidative stress indices such as lipid peroxides level and activities of antioxidant enzymes such as @PROTEIN$ and catalase, and some hematological parameters after treatment of subclinically ketotic lactating cows with antioxidants, vitamin E and @COMPOUND$, incorporated in conventional treatment regimen.	0
307	The present investigation was carried out to assess the erythrocytic oxidative stress indices such as lipid peroxides level and activities of antioxidant enzymes such as superoxide dismutase and @PROTEIN$, and some hematological parameters after treatment of subclinically ketotic lactating cows with antioxidants, vitamin E and @COMPOUND$, incorporated in conventional treatment regimen.	0
308	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (@PROTEIN$) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (@COMPOUND$) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1
309	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (@PROTEIN$) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (@COMPOUND$ ((S)-EHB), were investigated.	1
310	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (ADH) and glucose-6-phosphate dehydrogenase (@PROTEIN$) in brewer's yeast, and the corresponding capacity for the bioconversion of @COMPOUND$ (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1
311	The effects of industrial storage on the changes of the cell viability and the activities of intracellular @PROTEIN$ (ADH) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of @COMPOUND$ (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1
312	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (@PROTEIN$) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-@COMPOUND$), were investigated.	1
313	The effects of industrial storage on the changes of the cell viability and the activities of intracellular @PROTEIN$ (ADH) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-@COMPOUND$), were investigated.	1
314	The effects of industrial storage on the changes of the cell viability and the activities of intracellular @PROTEIN$ (ADH) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (@COMPOUND$) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1
315	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (ADH) and glucose-6-phosphate dehydrogenase (@PROTEIN$) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-@COMPOUND$), were investigated.	1
316	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (ADH) and glucose-6-phosphate dehydrogenase (@PROTEIN$) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (@COMPOUND$ ((S)-EHB), were investigated.	1
317	The effects of industrial storage on the changes of the cell viability and the activities of intracellular @PROTEIN$ (ADH) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (@COMPOUND$ ((S)-EHB), were investigated.	1
318	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (ADH) and glucose-6-phosphate dehydrogenase (@PROTEIN$) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (@COMPOUND$) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1
319	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (@PROTEIN$) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of @COMPOUND$ (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1
320	The intracellular levels of @PROTEIN$ and G6PDH after permeabilization of these stored cells with cetyltrimetylammonium bromide (@COMPOUND$) were much higher, which showed only slight decrease within 2 weeks during the industrial storage.	1
321	The intracellular levels of ADH and @PROTEIN$ after permeabilization of these stored cells with cetyltrimetylammonium bromide (@COMPOUND$) were much higher, which showed only slight decrease within 2 weeks during the industrial storage.	1
322	@COMPOUND$ effects on neuronal ultrastructure and expression of @PROTEIN$ (MAP2) in rats with acute spinal cord injury.	1
323	@COMPOUND$ effects on neuronal ultrastructure and expression of microtubule-associated protein 2 (@PROTEIN$) in rats with acute spinal cord injury.	1
324	(4) Our data indicated that @COMPOUND$ maintained in part neuronal ultrastructure, attenuated chromatolysis, and preclude the loss of @PROTEIN$, suggesting a protective effect during the early phases of spinal cord injury.	1
325	Two related polytopic @PROTEIN$ of the major facilitator family, NarK and NarU, catalyse @COMPOUND$ uptake, nitrite export and nitrite uptake across the Escherichia coli cytoplasmic membrane by an unknown mechanism.	0
326	Two related polytopic membrane proteins of the major facilitator family, NarK and @PROTEIN$, catalyse @COMPOUND$ uptake, nitrite export and nitrite uptake across the Escherichia coli cytoplasmic membrane by an unknown mechanism.	1
327	Two related polytopic membrane proteins of the major facilitator family, @PROTEIN$ and NarU, catalyse @COMPOUND$ uptake, nitrite export and nitrite uptake across the Escherichia coli cytoplasmic membrane by an unknown mechanism.	1
328	The relationships among obesity, metabolic syndrome, ED, sex hormone-binding globulin (@PROTEIN$) and serum total and free @COMPOUND$ levels are complex and often confusing to the physician.	1
329	In the present study, we investigated whether CD147/basigin is involved, via its association with @PROTEIN$ and 4 to transport @COMPOUND$, in glycolysis and then contributes to the progression of A375 melanoma cells.	1
330	In the present study, we investigated whether CD147/@PROTEIN$ is involved, via its association with MCT1 and 4 to transport @COMPOUND$, in glycolysis and then contributes to the progression of A375 melanoma cells.	1
331	It represents transition in @COMPOUND$-deprived conditions, known to lead to H2 production in Chlamydomonas reinhardtii, and the two main processes then induced which are an over-accumulation of intracellular starch and a progressive reduction of @PROTEIN$ activity for anoxia achievement.	1
332	The proportion of @PROTEIN$ molecules that are directed to the novel cleavage pathway is regulated by the ratio of free @COMPOUND$ and cholesteryl esters in cells.	1
333	The @PROTEIN$-deficient mouse, which develops atherosclerotic lesions rapidly when fed @COMPOUND$, was used to determine the ability of dried plums to reduce atherosclerosis.	0
334	Urinary @COMPOUND$-reactive substances (TBARS) excretion and serum amyloid P-component (@PROTEIN$) were measured as indicators of oxidative stress and inflammation, respectively.	0
335	Urinary @COMPOUND$-reactive substances (TBARS) excretion and @PROTEIN$ (SAP) were measured as indicators of oxidative stress and inflammation, respectively.	0
336	Our findings suggest that @PROTEIN$ substituted with a PEG of an appropriate Mw at Lys (34) could be used as a promising type 2 anti-diabetic agent to timely control postprandial @COMPOUND$ levels.	1
337	BDNF, NGF, adrenocorticotropic hormone (ACTH), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (@PROTEIN$) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0
338	@PROTEIN$, NGF, adrenocorticotropic hormone (ACTH), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0
339	BDNF, NGF, @PROTEIN$ (ACTH), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0
340	BDNF, NGF, adrenocorticotropic hormone (ACTH), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and @PROTEIN$ procedures.	0
341	BDNF, @PROTEIN$, adrenocorticotropic hormone (ACTH), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0
342	BDNF, NGF, adrenocorticotropic hormone (@PROTEIN$), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0
343	BDNF, NGF, adrenocorticotropic hormone (ACTH), @COMPOUND$ and @PROTEIN$ (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0
344	Transformation was achieved using a vector that targets genes to the rrn16/rps12 intergenic region of the sugar beet plastome, employing the @PROTEIN$ gene as a selectable marker against @COMPOUND$ and the gfp gene for visual screening of plastid transformants.	1
345	Transformation was achieved using a vector that targets genes to the rrn16/@PROTEIN$ intergenic region of the sugar beet plastome, employing the aadA gene as a selectable marker against @COMPOUND$ and the gfp gene for visual screening of plastid transformants.	0
346	Since then, the efforts of numerous investigators have led to the following conclusions: (a) This enzyme is indeed the molecular machine for the @COMPOUND$-dependent and-coupled transport of Na (+) and K(+) across the plasma membrane of a living cell in which such a process (@PROTEIN$) is detected.	1
347	Since then, the efforts of numerous investigators have led to the following conclusions: (a) This enzyme is indeed the molecular machine for the ATP-dependent and-coupled transport of @COMPOUND$ (+) and K(+) across the plasma membrane of a living cell in which such a process (@PROTEIN$) is detected.	1
348	The prevalence rates of elevated blood pressure and hypertriglyceridemia were significantly higher among HCT recipients than among controls, but the prevalence rates of abdominal obesity, elevated blood @COMPOUND$ and low @PROTEIN$ cholesterol were not.	0
349	The prevalence rates of elevated blood pressure and hypertriglyceridemia were significantly higher among HCT recipients than among controls, but the prevalence rates of abdominal obesity, elevated blood glucose and low @PROTEIN$ @COMPOUND$ were not.	1
350	Seleno-L-methionine (SeMet) can be oxidized to L-methionine selenoxide (MetSeO) by flavin-containing monooxygenase 3 (@PROTEIN$) and rat liver microsomes in the presence of @COMPOUND$.	1
351	The role of @COMPOUND$ in the treatment of obesity through @PROTEIN$ antagonism.	1
352	In men there is a large interindividual variation of @PROTEIN$ levels and consequently of @COMPOUND$ (T) and E(2) levels.	1
353	Acylated ghrelin and TNF α, @PROTEIN$ γ, IL-1β and IL-6 were measured with @COMPOUND$.	0
354	Acylated ghrelin and @PROTEIN$ α, IFN γ, IL-1β and IL-6 were measured with @COMPOUND$.	0
355	Acylated @PROTEIN$ and TNF α, IFN γ, IL-1β and IL-6 were measured with @COMPOUND$.	0
356	Acylated ghrelin and TNF α, IFN γ, IL-1β and @PROTEIN$ were measured with @COMPOUND$.	0
357	@COMPOUND$ reverses ET-1-evoked mitogenic effects in human coronary arterial cells by activating the kinase-G to inhibit @PROTEIN$-enzymes.	1
358	@COMPOUND$ reverses @PROTEIN$-evoked mitogenic effects in human coronary arterial cells by activating the kinase-G to inhibit ERK-enzymes.	1
359	Pretreatment with the MEK-ERK inhibitor (@COMPOUND$) appreciably reversed the mitogenic effects of @PROTEIN$.	1
360	On the other hand, pretreatment with the polyphenolic @COMPOUND$ resveratrol (RSVL, 1-100 microM) triggered more prominent inhibition of ET-1-evoked cell proliferation and @PROTEIN$/2 activation.	0
361	On the other hand, pretreatment with the polyphenolic stilbene @COMPOUND$ (RSVL, 1-100 microM) triggered more prominent inhibition of ET-1-evoked cell proliferation and @PROTEIN$/2 activation.	1
362	Further, pretreatment with the specific cGMP-phosphodiesterase inhibitor, @COMPOUND$ (10 microM) appreciably augmented RSVL-evoked cGMP formation, @PROTEIN$ inhibition, and cytostatic response.	1
363	Moreover, the RSVL-induced @PROTEIN$-inhibitory effects were significantly reversed by the kinase-G inhibitor, KT-5823 (10 microM; 69%), but not by the kinase-A inhibitor (@COMPOUND$).	0
364	Moreover, the RSVL-induced @PROTEIN$-inhibitory effects were significantly reversed by the kinase-G inhibitor, @COMPOUND$ (10 microM; 69%), but not by the kinase-A inhibitor (KT-5720).	1
365	To test this hypothesis, we investigated whether disruption of the oxytocin gene (@PROTEIN$-/-) made mice more susceptible to the psychosis-related effects of amphetamine (Amp), @COMPOUND$ (Apo) and phencyclidine (PCP).	0
366	To test this hypothesis, we investigated whether disruption of the @PROTEIN$ gene (Oxt-/-) made mice more susceptible to the psychosis-related effects of amphetamine (@COMPOUND$), apomorphine (Apo) and phencyclidine (PCP).	0
367	To test this hypothesis, we investigated whether disruption of the @PROTEIN$ gene (Oxt-/-) made mice more susceptible to the psychosis-related effects of amphetamine (Amp), @COMPOUND$ (Apo) and phencyclidine (PCP).	0
368	To test this hypothesis, we investigated whether disruption of the @PROTEIN$ gene (Oxt-/-) made mice more susceptible to the psychosis-related effects of @COMPOUND$ (Amp), apomorphine (Apo) and phencyclidine (PCP).	0
369	To test this hypothesis, we investigated whether disruption of the oxytocin gene (@PROTEIN$-/-) made mice more susceptible to the psychosis-related effects of @COMPOUND$ (Amp), apomorphine (Apo) and phencyclidine (PCP).	0
370	To test this hypothesis, we investigated whether disruption of the oxytocin gene (@PROTEIN$-/-) made mice more susceptible to the psychosis-related effects of amphetamine (Amp), apomorphine (Apo) and @COMPOUND$ (PCP).	0
371	To test this hypothesis, we investigated whether disruption of the @PROTEIN$ gene (Oxt-/-) made mice more susceptible to the psychosis-related effects of amphetamine (Amp), apomorphine (Apo) and @COMPOUND$ (PCP).	0
372	To test this hypothesis, we investigated whether disruption of the oxytocin gene (@PROTEIN$-/-) made mice more susceptible to the psychosis-related effects of amphetamine (@COMPOUND$), apomorphine (Apo) and phencyclidine (PCP).	0
373	@PROTEIN$ (GAD) is the rate-limiting enzyme in the synthesis of gamma-aminobutyric acid (@COMPOUND$), the most important inhibitory neurotransmitter in central nervous system (CNS).	1
374	Glutamate decarboxylase (@PROTEIN$) is the rate-limiting enzyme in the synthesis of @COMPOUND$ (GABA), the most important inhibitory neurotransmitter in central nervous system (CNS).	1
375	Glutamate decarboxylase (@PROTEIN$) is the rate-limiting enzyme in the synthesis of gamma-aminobutyric acid (@COMPOUND$), the most important inhibitory neurotransmitter in central nervous system (CNS).	1
376	@PROTEIN$ (GAD) is the rate-limiting enzyme in the synthesis of @COMPOUND$ (GABA), the most important inhibitory neurotransmitter in central nervous system (CNS).	1
377	These transcripts were predicted to synthesis of @PROTEIN$ proteins truncated of the binding site for @COMPOUND$, an essential cofactor, therefore cannot function as a decarboxylase.	1
378	Adenosine nucleotide translocase (@PROTEIN$) translocates ADP/@COMPOUND$ across the inner mitochondrial membrane.	1
379	Calcineurin inhibitors (CsA, @COMPOUND$ and pimecrolimus) inhibited NO production and @PROTEIN$ expression in a concentration-dependent manner, CsA being more potent than FK-506 and pimecrolimus.	1
380	Calcineurin inhibitors (CsA, FK-506 and @COMPOUND$) inhibited NO production and @PROTEIN$ expression in a concentration-dependent manner, CsA being more potent than FK-506 and pimecrolimus.	1
381	In conclusion, the results suggest that calcineurin inhibitors cyclosporin A, tacrolimus (FK-506) and @COMPOUND$ inhibit @PROTEIN$ expression and NO production in response to inflammatory stimuli by enhancing the decay of iNOS mRNA by a 3'UTR-dependent manner.	1
382	In conclusion, the results suggest that calcineurin inhibitors @COMPOUND$, tacrolimus (FK-506) and pimecrolimus inhibit @PROTEIN$ expression and NO production in response to inflammatory stimuli by enhancing the decay of iNOS mRNA by a 3'UTR-dependent manner.	1
383	In conclusion, the results suggest that calcineurin inhibitors cyclosporin A, @COMPOUND$ (FK-506) and pimecrolimus inhibit @PROTEIN$ expression and NO production in response to inflammatory stimuli by enhancing the decay of iNOS mRNA by a 3'UTR-dependent manner.	1
384	In conclusion, the results suggest that calcineurin inhibitors cyclosporin A, tacrolimus (@COMPOUND$) and pimecrolimus inhibit @PROTEIN$ expression and NO production in response to inflammatory stimuli by enhancing the decay of iNOS mRNA by a 3'UTR-dependent manner.	1
385	Linear regression analyses showed that @COMPOUND$ and phospholipid efflux and cellular apoA-I binding correlated significantly with the ability of @PROTEIN$ to form cell surface lipid domains.	1
386	Linear regression analyses showed that @COMPOUND$ and phospholipid efflux and cellular @PROTEIN$ binding correlated significantly with the ability of ABCA1 to form cell surface lipid domains.	0
387	Changes in @PROTEIN$ (TNF) production by lipopolysaccharide-stimulated peripheral blood mononuclear cells significantly correlated with serum P levels in postmenopausal women subjected to estrogen/@COMPOUND$ therapy.	0
388	Changes in tumor necrosis factor (@PROTEIN$) production by @COMPOUND$-stimulated peripheral blood mononuclear cells significantly correlated with serum P levels in postmenopausal women subjected to estrogen/medroxyprogesterone therapy.	1
389	Changes in @PROTEIN$ (TNF) production by @COMPOUND$-stimulated peripheral blood mononuclear cells significantly correlated with serum P levels in postmenopausal women subjected to estrogen/medroxyprogesterone therapy.	1
390	Changes in tumor necrosis factor (@PROTEIN$) production by lipopolysaccharide-stimulated peripheral blood mononuclear cells significantly correlated with serum P levels in postmenopausal women subjected to estrogen/@COMPOUND$ therapy.	0
391	Decreases in PNNs, aggrecan and @COMPOUND$ were observed only in the terminal stages and correlated with the distribution of @PROTEIN$ (BSE) and activated glial cells.	1
392	This study suggests that the loss of PNNs, aggrecan and @COMPOUND$ is a consequence of @PROTEIN$ (BSE) accumulation.	0
393	This study suggests that the loss of @PROTEIN$, aggrecan and @COMPOUND$ is a consequence of PrP (BSE) accumulation.	0
394	A subthreshold stimulation by acute pathological threatening conditions (e.g., global ischemia subthreshold for cell death) enhances neuronal @PROTEIN$ and glial Cx43 hemichannel activity, favoring @COMPOUND$ release and generation of preconditioning.	1
395	A subthreshold stimulation by acute pathological threatening conditions (e.g., global ischemia subthreshold for cell death) enhances neuronal Cx36 and glial @PROTEIN$ hemichannel activity, favoring @COMPOUND$ release and generation of preconditioning.	1
396	Treatment with acidified saline reduced fetal basal pH from 7.35+/-0.01 to 7.29+/-0.01 but did not alter basal cardiovascular variables, blood @COMPOUND$, or plasma concentrations of catecholamines, @PROTEIN$, and cortisol.	0
397	Treatment with acidified saline reduced fetal basal pH from 7.35+/-0.01 to 7.29+/-0.01 but did not alter basal cardiovascular variables, blood glucose, or plasma concentrations of catecholamines, @PROTEIN$, and @COMPOUND$.	0
398	During hypoxemia, treatment with acidified saline increased the magnitude of the fetal bradycardia and femoral vasoconstriction and concomitantly increased chemoreflex function and enhanced the increments in plasma concentrations of catecholamines, @PROTEIN$, and @COMPOUND$.	0
399	In our microarray analysis we observed that Seven-in-Absentia Homolog 2 (SIAH2) levels were low in @PROTEIN$ (ER) positive breast tumors of patients resistant to first-line @COMPOUND$ therapy.	1
400	In our microarray analysis we observed that @PROTEIN$ (SIAH2) levels were low in estrogen receptor (ER) positive breast tumors of patients resistant to first-line @COMPOUND$ therapy.	1
401	In our microarray analysis we observed that Seven-in-Absentia Homolog 2 (@PROTEIN$) levels were low in estrogen receptor (ER) positive breast tumors of patients resistant to first-line @COMPOUND$ therapy.	1
402	Based on these findings, altered expression of @PROTEIN$ in most areas of the striatum suggests that widespread changes to the myelin structure could be associated with the adaptive changes following chronic @COMPOUND$ abuse.	1
403	A sensitive and specific ELISA detects @COMPOUND$-containing @PROTEIN$ in HDL.	1
404	A wide range of reactive intermediates oxidizes methionine residues to @COMPOUND$ (MetO) in @PROTEIN$ (apoA-I), the major HDL protein.	1
405	A wide range of reactive intermediates oxidizes methionine residues to @COMPOUND$ (MetO) in apolipoprotein A-I (@PROTEIN$), the major HDL protein.	1
406	Association between serum retinol-binding @PROTEIN$ and small dense low-density lipoprotein @COMPOUND$ levels in young adult women.	1
407	Effect of genetic polymorphisms of @PROTEIN$ and MDR1 on @COMPOUND$ concentration during the early stage after renal transplantation in Chinese patients co-treated with diltiazem.	0
408	Effect of genetic polymorphisms of @PROTEIN$ and MDR1 on cyclosporine concentration during the early stage after renal transplantation in Chinese patients co-treated with @COMPOUND$.	0
409	Effect of genetic polymorphisms of CYP3A5 and @PROTEIN$ on cyclosporine concentration during the early stage after renal transplantation in Chinese patients co-treated with @COMPOUND$.	0
410	Effect of genetic polymorphisms of CYP3A5 and @PROTEIN$ on @COMPOUND$ concentration during the early stage after renal transplantation in Chinese patients co-treated with diltiazem.	0
411	The aim of this study was to assess the influence of the cytochrome (CYP450)3A5 and multidrug resistance (@PROTEIN$) gene polymorphisms on @COMPOUND$ (CsA) trough concentration during the early stage after renal transplantation in Chinese patients co-treated with diltiazem.	0
412	The aim of this study was to assess the influence of the cytochrome (CYP450)3A5 and multidrug resistance (@PROTEIN$) gene polymorphisms on cyclosporine A (CsA) trough concentration during the early stage after renal transplantation in Chinese patients co-treated with @COMPOUND$.	0
413	Studies of HeLa cells and serum- and glucocorticoid-regulated kinase 1 (SGK1) knockout mice identified @COMPOUND$ residues in the @PROTEIN$ (NDRG1-Thr (346/356/366)) that are phosphorylated by SGK1 but not by related kinases (Murray et al., Biochem J 385:1-12, 2005).	1
414	Studies of HeLa cells and serum- and glucocorticoid-regulated kinase 1 (SGK1) knockout mice identified @COMPOUND$ residues in the n-myc downstream-regulated gene 1 protein (@PROTEIN$-Thr (346/356/366)) that are phosphorylated by SGK1 but not by related kinases (Murray et al., Biochem J 385:1-12, 2005).	1
415	Although G (Na) is negligible in hormone-deprived cells, these cells displayed basal @PROTEIN$ activity that was sensitive to @COMPOUND$, an inhibitor of 3-phosphatidylinositol phosphate kinase (PI3K).	1
416	Following an oral @COMPOUND$ challenge, there was a weak trend for glucose-stimulated @PROTEIN$ release to be increased in the offspring of dams fed the folate-deficient diet.	1
417	Fibril growth was a second-order process with an enthalpy of activation (27+/-5 kcal mol(-1)), which is indistinguishable from that of tetramer formation by @PROTEIN$, which involves limited conformational changes including @COMPOUND$ trans to cis isomerization.	1
418	Mechanism-based inactivation of @PROTEIN$ by tienilic acid and (+/-)-@COMPOUND$ : a comparison of kinetics and probe substrate selection.	1
419	Mechanism-based inactivation of @PROTEIN$ by @COMPOUND$ and (+/-)-suprofen : a comparison of kinetics and probe substrate selection.	1
420	In vitro experiments were conducted to compare k(inact), K(I) and inactivation efficiency (k(inact)/K(I)) of @PROTEIN$ (P450) 2C9 by @COMPOUND$ and (+/-)-suprofen using (S)-flurbiprofen, diclofenac, and (S)-warfarin as reporter substrates.	1
421	In vitro experiments were conducted to compare k(inact), K(I) and inactivation efficiency (k(inact)/K(I)) of @PROTEIN$ (P450) 2C9 by tienilic acid and (+/-)-@COMPOUND$ using (S)-flurbiprofen, diclofenac, and (S)-warfarin as reporter substrates.	1
422	Effects of exhaustion and calcium supplementation on @PROTEIN$ and @COMPOUND$ levels in athletes.	0
423	The present study was performed to investigate the effects of strenuous exercise and calcium supplementation on @COMPOUND$ and @PROTEIN$ levels in athletes at rest and exhaustion.	0
424	One-month supplementation with calcium does not influence the @COMPOUND$ and @PROTEIN$ 0.05).	0
425	This analysis reveals @PROTEIN$ as major and unsuspected gates of @COMPOUND$+) entry that contribute, depending on context, to activation of transcription factors, apoptosis, vascular contractility, platelet activation, and cardiac hypertrophy, as well as to normal and abnormal cell proliferation.	1
426	Both MudPIT and cDNA microarray analyses indicate that @COMPOUND$ treatment caused elevated levels of @PROTEIN$.	1
427	The purpose of this study was to propose a new preparation method to fabricate @PROTEIN$-loaded poly(lactic-coglycolic acid) (@COMPOUND$) microparticles satisfying protein loading, release profiles, burst release, and particularly stability of the encapsulated protein.	1
428	As metabolic flux for the operation of the @COMPOUND$ pathway is maintained through the activities of @PROTEIN$ and C4H, thus, catechins biosynthesis in tea is critically dependent on the products of these enzymes.	1
429	As metabolic flux for the operation of the @COMPOUND$ pathway is maintained through the activities of PAL and @PROTEIN$, thus, catechins biosynthesis in tea is critically dependent on the products of these enzymes.	1
430	@PROTEIN$ is responsible for the sulfation and inactivation of @COMPOUND$ (E2) at physiological concentrations.	1
431	We monitored bcr-@PROTEIN$ transcript levels by quantitative real time PCR in 50 tunisian patients treated with @COMPOUND$ for chronic myeloid leukemia in chronic phase for a median of 29 months (3-60) after they started imatinib.	0
432	We monitored @PROTEIN$-abl transcript levels by quantitative real time PCR in 50 tunisian patients treated with @COMPOUND$ for chronic myeloid leukemia in chronic phase for a median of 29 months (3-60) after they started imatinib.	0
433	Whereas Zn2+-dependent upregulation of @PROTEIN$ may help to counteract excessive astrocyte swelling and production of reactive oxygen and @COMPOUND$ species, stimulation of PBR expression may augment HE development.	1
434	Whereas Zn2+-dependent upregulation of metallothionein may help to counteract excessive astrocyte swelling and production of reactive oxygen and @COMPOUND$ species, stimulation of @PROTEIN$ expression may augment HE development.	0
435	Whereas @COMPOUND$+-dependent upregulation of metallothionein may help to counteract excessive astrocyte swelling and production of reactive oxygen and nitrogen oxide species, stimulation of @PROTEIN$ expression may augment HE development.	0
436	Whereas Zn2+-dependent upregulation of @PROTEIN$ may help to counteract excessive astrocyte swelling and production of reactive @COMPOUND$ and nitrogen oxide species, stimulation of PBR expression may augment HE development.	1
437	Whereas Zn2+-dependent upregulation of metallothionein may help to counteract excessive astrocyte swelling and production of reactive @COMPOUND$ and nitrogen oxide species, stimulation of @PROTEIN$ expression may augment HE development.	0
438	Whereas @COMPOUND$+-dependent upregulation of @PROTEIN$ may help to counteract excessive astrocyte swelling and production of reactive oxygen and nitrogen oxide species, stimulation of PBR expression may augment HE development.	1
439	Since lithium and @COMPOUND$-induced G(2)/M arrest we studied changes in the expression of proteins involved in this phase, specifically @PROTEIN$ B, cdc2 and the phosphorylated form of this protein (tyr15-cdc2).	0
440	Since @COMPOUND$ and SB-415286-induced G(2)/M arrest we studied changes in the expression of proteins involved in this phase, specifically cyclin B, @PROTEIN$ and the phosphorylated form of this protein (tyr15-cdc2).	0
441	Since lithium and @COMPOUND$-induced G(2)/M arrest we studied changes in the expression of proteins involved in this phase, specifically cyclin B, @PROTEIN$ and the phosphorylated form of this protein (tyr15-cdc2).	0
442	Since @COMPOUND$ and SB-415286-induced G(2)/M arrest we studied changes in the expression of proteins involved in this phase, specifically @PROTEIN$ B, cdc2 and the phosphorylated form of this protein (tyr15-cdc2).	0
443	On the other hand, @COMPOUND$ increased the expression of @PROTEIN$, involved in the regulation of proliferation.	1
444	We conclude that inhibitors of GSK-3 induced cell-cycle arrest, mediated by the phosphorylation of cdc2 and, in the case of @COMPOUND$, @PROTEIN$ expression, which induced apoptosis in a caspase-independent manner.	1
445	We conclude that inhibitors of GSK-3 induced cell-cycle arrest, mediated by the phosphorylation of @PROTEIN$ and, in the case of @COMPOUND$, SIRT2 expression, which induced apoptosis in a caspase-independent manner.	0
446	The anti-inflammatory effect of these compounds and a @COMPOUND$ control, scopoletin, on interleukin-6 (IL-6), @PROTEIN$ (TNF), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0
447	The anti-inflammatory effect of these compounds and a @COMPOUND$ control, scopoletin, on @PROTEIN$ (IL-6), tumor necrosis factor (TNF), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	1
448	The anti-inflammatory effect of these compounds and a @COMPOUND$ control, scopoletin, on interleukin-6 (IL-6), tumor necrosis factor (TNF), and macrophage chemotactic protein-1 (@PROTEIN$) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0
449	The anti-inflammatory effect of these compounds and a coumarin control, @COMPOUND$, on interleukin-6 (IL-6), tumor necrosis factor (@PROTEIN$), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0
450	The anti-inflammatory effect of these compounds and a @COMPOUND$ control, scopoletin, on interleukin-6 (@PROTEIN$), tumor necrosis factor (TNF), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0
451	The anti-inflammatory effect of these compounds and a coumarin control, @COMPOUND$, on interleukin-6 (IL-6), @PROTEIN$ (TNF), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0
452	The anti-inflammatory effect of these compounds and a coumarin control, @COMPOUND$, on @PROTEIN$ (IL-6), tumor necrosis factor (TNF), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0
453	The anti-inflammatory effect of these compounds and a coumarin control, @COMPOUND$, on interleukin-6 (IL-6), tumor necrosis factor (TNF), and macrophage chemotactic protein-1 (@PROTEIN$) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0
454	The anti-inflammatory effect of these compounds and a @COMPOUND$ control, scopoletin, on interleukin-6 (IL-6), tumor necrosis factor (@PROTEIN$), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0
455	The anti-inflammatory effect of these compounds and a coumarin control, @COMPOUND$, on interleukin-6 (@PROTEIN$), tumor necrosis factor (TNF), and macrophage chemotactic protein-1 (MCP-1) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	0
456	@PROTEIN$ reduces antioxidant defense system and enhances kidney tissue damage in @COMPOUND$ and lead exposed rats.	1
457	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (@COMPOUND$-Px) activities as well as the level of malondialdehyde (MDA) in the kidney.	0
458	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (@COMPOUND$-Px) activities as well as the level of malondialdehyde (MDA) in the kidney.	0
459	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on @PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (@COMPOUND$-Px) activities as well as the level of malondialdehyde (MDA) in the kidney.	0
460	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GSH-Px) activities as well as the level of @COMPOUND$ (MDA) in the kidney.	0
461	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GSH-Px) activities as well as the level of @COMPOUND$ (MDA) in the kidney.	0
462	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (@COMPOUND$-Px) activities as well as the level of malondialdehyde (MDA) in the kidney.	0
463	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GSH-Px) activities as well as the level of @COMPOUND$ (MDA) in the kidney.	0
464	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (@COMPOUND$-Px) activities as well as the level of malondialdehyde (MDA) in the kidney.	0
465	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on @PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px) activities as well as the level of @COMPOUND$ (MDA) in the kidney.	0
466	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GSH-Px) activities as well as the level of @COMPOUND$ (MDA) in the kidney.	0
467	Gender differences in corticotropin and @COMPOUND$ secretion and @PROTEIN$ mRNA expression in the paraventricular nucleus of the hypothalamus and the central nucleus of the amygdala in response to footshock stress or psychological stress in rats.	0
468	Gender differences in @PROTEIN$ and @COMPOUND$ secretion and corticotropin-releasing factor mRNA expression in the paraventricular nucleus of the hypothalamus and the central nucleus of the amygdala in response to footshock stress or psychological stress in rats.	0
469	Although females in both proestrus and diestrus showed significant increases in plasma @PROTEIN$ and @COMPOUND$ and CRF mRNA expression in the PVN in response to PS, no significant responses of the HPA axis to PS were found in males.	0
470	Although females in both proestrus and diestrus showed significant increases in plasma ACTH and @COMPOUND$ and @PROTEIN$ mRNA expression in the PVN in response to PS, no significant responses of the HPA axis to PS were found in males.	0
471	We measured serum high-sensitivity C-reactive protein (hs-@PROTEIN$), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, fibrinogen, @COMPOUND$, high-density lipoprotein (HDL), triglycerides and parathormone).	0
472	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, @PROTEIN$, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, @COMPOUND$ product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
473	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, @PROTEIN$, @COMPOUND$, high-density lipoprotein (HDL), triglycerides and parathormone).	0
474	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, @PROTEIN$, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum @COMPOUND$, calcium-phosphate product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
475	We measured serum high-sensitivity C-reactive protein (hs-CRP), @PROTEIN$, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, fibrinogen, @COMPOUND$, high-density lipoprotein (HDL), triglycerides and parathormone).	0
476	We measured serum high-sensitivity C-reactive protein (hs-@PROTEIN$), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, @COMPOUND$ product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
477	We measured serum high-sensitivity C-reactive protein (hs-CRP), @PROTEIN$, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum @COMPOUND$, calcium-phosphate product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
478	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, @PROTEIN$, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, fibrinogen, @COMPOUND$, high-density lipoprotein (HDL), triglycerides and parathormone).	0
479	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, @PROTEIN$, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, fibrinogen, @COMPOUND$, high-density lipoprotein (HDL), triglycerides and parathormone).	0
480	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum @COMPOUND$, calcium-phosphate product, albumin, fibrinogen, cholesterol, @PROTEIN$ (HDL), triglycerides and parathormone).	0
481	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, fibrinogen, @COMPOUND$, @PROTEIN$ (HDL), triglycerides and parathormone).	0
482	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, @PROTEIN$, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum @COMPOUND$, calcium-phosphate product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
483	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, @COMPOUND$ product, albumin, @PROTEIN$, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
484	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, @COMPOUND$ product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and @PROTEIN$).	0
485	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, @PROTEIN$ (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, @COMPOUND$ product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
486	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, @PROTEIN$ (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, fibrinogen, @COMPOUND$, high-density lipoprotein (HDL), triglycerides and parathormone).	0
487	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, @PROTEIN$, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, @COMPOUND$ product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
488	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, @COMPOUND$ product, albumin, fibrinogen, cholesterol, @PROTEIN$ (HDL), triglycerides and parathormone).	0
489	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, calcium-phosphate product, albumin, fibrinogen, @COMPOUND$, high-density lipoprotein (HDL), triglycerides and @PROTEIN$).	0
490	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, @PROTEIN$ (ELISA) and others (haemoglobin level, white blood cell count, serum @COMPOUND$, calcium-phosphate product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
491	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum @COMPOUND$, calcium-phosphate product, albumin, @PROTEIN$, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
492	We measured serum high-sensitivity C-reactive protein (hs-CRP), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum @COMPOUND$, calcium-phosphate product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and @PROTEIN$).	0
493	We measured serum high-sensitivity C-reactive protein (hs-@PROTEIN$), fetuin-A, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum @COMPOUND$, calcium-phosphate product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
494	We measured serum high-sensitivity C-reactive protein (hs-CRP), @PROTEIN$, IL-6, IL-18, IL-10 (ELISA) and others (haemoglobin level, white blood cell count, serum calcium, phosphate, @COMPOUND$ product, albumin, fibrinogen, cholesterol, high-density lipoprotein (HDL), triglycerides and parathormone).	0
495	Models of noncoupled dinuclear @COMPOUND$ centers in @PROTEIN$.	1
496	Toward this goal, models of the noncoupled @COMPOUND$ centers found in the enzymes peptidyl alpha-hydroxylating monooxygenase (@PROTEIN$), dopamine beta-monooxygenase (DBM), and nitrite reductase (NiR) were designed into the small soluble protein azurin.	1
497	Toward this goal, models of the noncoupled @COMPOUND$ centers found in the enzymes peptidyl alpha-hydroxylating monooxygenase (PHM), dopamine beta-monooxygenase (DBM), and nitrite reductase (NiR) were designed into the small soluble protein @PROTEIN$.	1
498	Toward this goal, models of the noncoupled @COMPOUND$ centers found in the enzymes peptidyl alpha-hydroxylating monooxygenase (PHM), dopamine beta-monooxygenase (DBM), and nitrite reductase (@PROTEIN$) were designed into the small soluble protein azurin.	1
499	Toward this goal, models of the noncoupled @COMPOUND$ centers found in the enzymes peptidyl alpha-hydroxylating monooxygenase (PHM), @PROTEIN$ (DBM), and nitrite reductase (NiR) were designed into the small soluble protein azurin.	1
500	The models are significant because they maintain the existing type 1 (T1) @COMPOUND$, electron transfer site of @PROTEIN$ while including the second designed type 2 (T2) copper center that mimics the T2 catalytic sites in the target enzymes.	1
501	Sex steroids enhance @PROTEIN$ and @COMPOUND$ oxidation in Chang liver cells.	0
502	The present study was designed to assess the effect of sex steroids (testosterone and 17beta-estradiol) on @PROTEIN$ receptor expression, insulin binding and @COMPOUND$ oxidation in human liver cell line.	0
503	The present study was designed to assess the effect of sex steroids (@COMPOUND$ and 17beta-estradiol) on @PROTEIN$ receptor expression, insulin binding and glucose oxidation in human liver cell line.	1
504	The present study was designed to assess the effect of sex steroids (testosterone and @COMPOUND$) on @PROTEIN$ receptor expression, insulin binding and glucose oxidation in human liver cell line.	1
505	The present study was designed to assess the effect of sex steroids (@COMPOUND$ and 17beta-estradiol) on @PROTEIN$ expression, insulin binding and glucose oxidation in human liver cell line.	1
506	The present study was designed to assess the effect of sex steroids (testosterone and 17beta-estradiol) on @PROTEIN$ expression, insulin binding and @COMPOUND$ oxidation in human liver cell line.	0
507	The present study was designed to assess the effect of sex steroids (testosterone and @COMPOUND$) on @PROTEIN$ expression, insulin binding and glucose oxidation in human liver cell line.	1
508	@PROTEIN$-alpha inhibition protects against @COMPOUND$-induced endothelial glycocalyx perturbation.	1
509	In the present study, we investigated whether @COMPOUND$-induced inflammatory reactions lead to a decrease of endothelial glycocalyx thickness in humans and whether @PROTEIN$-alpha (TNFalpha) plays a role in this process.	0
510	In the present study, we investigated whether @COMPOUND$-induced inflammatory reactions lead to a decrease of endothelial glycocalyx thickness in humans and whether tumor necrosis factor-alpha (@PROTEIN$) plays a role in this process.	0
511	These include typical G-protein (Galphaq/11)-coupled cascades, such as activation of phospholipase C (PLC), and subsequent accumulation of inositol-(1,4,5)-triphosphate (IP3), intracellular @COMPOUND$+) mobilization, and activation of @PROTEIN$.	0
512	They can be oxidized by @PROTEIN$ (SSAO), leading to the production of toxic aldehydes such as formaldehyde and @COMPOUND$ as well as hydrogen peroxide and ammonia.	1
513	They can be oxidized by @PROTEIN$ (SSAO), leading to the production of toxic aldehydes such as formaldehyde and methylglyoxal as well as @COMPOUND$ and ammonia.	1
514	They can be oxidized by @PROTEIN$ (SSAO), leading to the production of toxic aldehydes such as formaldehyde and methylglyoxal as well as hydrogen peroxide and @COMPOUND$.	1
515	They can be oxidized by @PROTEIN$ (SSAO), leading to the production of toxic aldehydes such as @COMPOUND$ and methylglyoxal as well as hydrogen peroxide and ammonia.	1
516	They can be oxidized by semicarbazide-sensitive amine oxidase (@PROTEIN$), leading to the production of toxic aldehydes such as formaldehyde and methylglyoxal as well as @COMPOUND$ and ammonia.	1
517	They can be oxidized by semicarbazide-sensitive amine oxidase (@PROTEIN$), leading to the production of toxic aldehydes such as @COMPOUND$ and methylglyoxal as well as hydrogen peroxide and ammonia.	1
518	They can be oxidized by semicarbazide-sensitive amine oxidase (@PROTEIN$), leading to the production of toxic aldehydes such as formaldehyde and @COMPOUND$ as well as hydrogen peroxide and ammonia.	1
519	They can be oxidized by semicarbazide-sensitive amine oxidase (@PROTEIN$), leading to the production of toxic aldehydes such as formaldehyde and methylglyoxal as well as hydrogen peroxide and @COMPOUND$.	1
520	Recent evidence for toxic @COMPOUND$ (O(2)(-)) production by marine microalgae is afforded particular attention given that release of O(2)(-) anions can be exacerbated by the binding of @PROTEIN$ to the microalgal cell wall ; a novel model for grazing-activated chemical defence is proposed.	1
521	To assess whether follicle-stimulating hormone (FSH) and basic fibroblast growth factor (bFGF) modulate @COMPOUND$ production in Sertoli cells by regulating the expression of GCLC, @PROTEIN$ and/or GR, we performed in vitro studies using rat Sertoli cells in primary culture.	0
522	To assess whether follicle-stimulating hormone (FSH) and @PROTEIN$ (bFGF) modulate @COMPOUND$ production in Sertoli cells by regulating the expression of GCLC, GCLM and/or GR, we performed in vitro studies using rat Sertoli cells in primary culture.	0
523	To assess whether follicle-stimulating hormone (FSH) and basic fibroblast growth factor (bFGF) modulate @COMPOUND$ production in Sertoli cells by regulating the expression of @PROTEIN$, GCLM and/or GR, we performed in vitro studies using rat Sertoli cells in primary culture.	0
524	In conclusion, our results show that FSH and bFGF increase @COMPOUND$ levels in Sertoli cells through stimulation of the de novo synthesis and recycling by upregulating @PROTEIN$ and GR expression respectively.	0
525	The considered biological model system consisted of a coating antibody (goat IgG), bovine serum albumin (@PROTEIN$) as blocking agent, and a complementary antibody labelled with @COMPOUND$ (anti-goat IgG).	0
526	The considered biological model system consisted of a coating antibody (goat IgG), bovine @PROTEIN$ (BSA) as blocking agent, and a complementary antibody labelled with @COMPOUND$ (anti-goat IgG).	0
527	There are data to suggest that psychological intervention can influence neuroendocrine (e.g., @COMPOUND$) and immune function indicators, especially lymphocyte proliferation and @PROTEIN$ cytokine production.	0
528	BrdU proliferation assays showed that in vivo proliferation of CD8+ T cells was reduced in @COMPOUND$-fed mice, and @PROTEIN$-dependent in vitro proliferation of naive CD8+ T cells was also reduced.	0
529	Immunocytochemical localization of cell surface markers like SSEA-3, SSEA-4, @COMPOUND$-1-60, and TRA-1-81, staining for alkaline phosphatase and @PROTEIN$ polymerase chain reaction (RT-PCR) analysis of pluripotency state markers viz.	0
530	Immunocytochemical localization of cell surface markers like @COMPOUND$, SSEA-4, TRA-1-60, and TRA-1-81, staining for alkaline phosphatase and @PROTEIN$ polymerase chain reaction (RT-PCR) analysis of pluripotency state markers viz.	0
531	Immunocytochemical localization of cell surface markers like SSEA-3, SSEA-4, @COMPOUND$-1-60, and TRA-1-81, staining for @PROTEIN$ and reverse transcriptase polymerase chain reaction (RT-PCR) analysis of pluripotency state markers viz.	0
532	Immunocytochemical localization of cell surface markers like SSEA-3, SSEA-4, @COMPOUND$-1-60, and TRA-1-81, staining for alkaline phosphatase and reverse transcriptase polymerase chain reaction (RT-@PROTEIN$) analysis of pluripotency state markers viz.	0
533	Immunocytochemical localization of cell surface markers like @COMPOUND$, SSEA-4, TRA-1-60, and TRA-1-81, staining for alkaline phosphatase and reverse transcriptase polymerase chain reaction (RT-@PROTEIN$) analysis of pluripotency state markers viz.	0
534	Immunocytochemical localization of cell surface markers like @COMPOUND$, SSEA-4, TRA-1-60, and TRA-1-81, staining for @PROTEIN$ and reverse transcriptase polymerase chain reaction (RT-PCR) analysis of pluripotency state markers viz.	0
535	Associations between the uptake of 111In-@COMPOUND$-trastuzumab, @PROTEIN$ density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts.	1
536	The purpose of the study was to investigate the associations between uptake of (111)In-@COMPOUND$-trastuzumab, tumour @PROTEIN$ density and response to trastuzumab (Herceptin) of human breast cancer (BC) xenografts in athymic mice.	1
537	She had a mutation in @PROTEIN$ gene consisting of an aminoacid change of Alanine to @COMPOUND$ in exon 5 (A382V).	1
538	She had a mutation in @PROTEIN$ gene consisting of an aminoacid change of @COMPOUND$ to Valine in exon 5 (A382V).	1
539	@COMPOUND$ increased the levels of CD95 (@PROTEIN$), CD95-ligand and Fas-associated death domain.	1
540	Achieving CCgR within 12 months and maintaining it without an increase in @PROTEIN$-ABL transcripts might indicate that low-dose @COMPOUND$ therapy can produce acceptable outcomes without excess toxicity.	1
541	Achieving CCgR within 12 months and maintaining it without an increase in BCR-@PROTEIN$ transcripts might indicate that low-dose @COMPOUND$ therapy can produce acceptable outcomes without excess toxicity.	1
542	Although the overall amino acid identity between @PROTEIN$ and the LeuT(Aa) is only 17%, it increases to above 50% in the first shell of the putative 5-HT binding site, allowing de novo computational docking of @COMPOUND$ derivatives in atomic detail.	0
543	The chimera was at least fourfold less sensitive to inhibition by okadaic acid, but was stimulated by nickel ions and @COMPOUND$, characteristics of @PROTEIN$ not of PP1.	1
544	The chimera was at least fourfold less sensitive to inhibition by okadaic acid, but was stimulated by @COMPOUND$ and chlorogenic acid, characteristics of @PROTEIN$ not of PP1.	1
545	The chimera was at least fourfold less sensitive to inhibition by okadaic acid, but was stimulated by @COMPOUND$ and chlorogenic acid, characteristics of PP2B not of @PROTEIN$.	0
546	The chimera was at least fourfold less sensitive to inhibition by okadaic acid, but was stimulated by nickel ions and @COMPOUND$, characteristics of PP2B not of @PROTEIN$.	0
547	Unfolding and inactivation of abalone (Haliotis diversicolor) @PROTEIN$ during denaturation by @COMPOUND$.	1
548	Unfolding and inactivation of @PROTEIN$ from abalone (Haliotis diversicolor) during denaturation by @COMPOUND$ (GuHCl) of different concentrations has first been studied.	1
549	Intracellular oxidative status was assessed by analysis of @COMPOUND$/GSSG levels and time course of ROS production and @PROTEIN$ (GR) activity.	0
550	Intracellular oxidative status was assessed by analysis of GSH/@COMPOUND$ levels and time course of ROS production and @PROTEIN$ (GR) activity.	0
551	The patterns of nerves immunoreactive (IR) to antibodies towards serotonin (@COMPOUND$) and the invertebrate @PROTEIN$ FMRFamide are described in relation to the musculature.	0
552	The patterns of nerves immunoreactive (IR) to antibodies towards @COMPOUND$ (5-HT) and the invertebrate neuropeptide @PROTEIN$ are described in relation to the musculature.	0
553	The patterns of nerves immunoreactive (IR) to antibodies towards @COMPOUND$ (5-HT) and the invertebrate @PROTEIN$ FMRFamide are described in relation to the musculature.	0
554	The patterns of nerves immunoreactive (IR) to antibodies towards serotonin (@COMPOUND$) and the invertebrate neuropeptide @PROTEIN$ are described in relation to the musculature.	0
555	Distribution of the @PROTEIN$ in the diencephalon and the pituitary gland in goats: Co-localisation with corticotrophin releasing hormone, @COMPOUND$ and corticotrophs.	0
556	To investigate overnight variations in absolute values and patterns of cytokines including interleukin 6 (@PROTEIN$) and tumour necrosis factor alpha (TNFalpha) in rheumatoid arthritis (RA), and to relate any changes to those occurring in blood @COMPOUND$.	0
557	To investigate overnight variations in absolute values and patterns of cytokines including interleukin 6 (IL6) and tumour necrosis factor alpha (@PROTEIN$) in rheumatoid arthritis (RA), and to relate any changes to those occurring in blood @COMPOUND$.	0
558	To investigate overnight variations in absolute values and patterns of cytokines including @PROTEIN$ (IL6) and tumour necrosis factor alpha (TNFalpha) in rheumatoid arthritis (RA), and to relate any changes to those occurring in blood @COMPOUND$.	0
559	In contrast, chelating intracellular calcium ((Ca(2+))(i)) by @COMPOUND$ abolished @PROTEIN$-mediated Arc up-regulation.	0
560	In contrast, chelating intracellular calcium ((@COMPOUND$+))(i)) by BAPTA-AM abolished @PROTEIN$-mediated Arc up-regulation.	0
561	These data suggested novel functions of (@COMPOUND$+))(i) and CaM in @PROTEIN$ signaling.	1
562	These data suggested novel functions of (@COMPOUND$+))(i) and @PROTEIN$ in BDNF signaling.	0
563	Comparison of the Arc transcription profiles between @COMPOUND$+)-stimulated and @PROTEIN$-stimulated neurons demonstrated that the regulatory mechanisms were distinctively tailored to the complex features of neuronal activity.	0
564	Identification of Aldh1a, @PROTEIN$ and RAR orthologs in protostomes pushes back the @COMPOUND$ genetic machinery in evolutionary time to the bilaterian ancestor.	1
565	Oral immunogenicity and protective efficacy in mice of transgenic rice plants producing a vaccine candidate antigen (@COMPOUND$) of Ascaris suum fused with cholera @PROTEIN$ subunit.	0
566	By using the system, we obtained four event timing data sets (stimulation by @PROTEIN$ with and without @COMPOUND$ at the concentrations of 0.01, 0.1, and 1 microM).	0
567	The effect on activation voltage but not that on amplitude was absent when expressing a cAMP-insensitive mutant (@PROTEIN$R/E), while a C-terminal truncated form of HCN2 (HCN2DeltaCx) exhibited only the voltage dependent but not the amplitude effect of @COMPOUND$.	1
568	Thus, the action of erbstatin on the activation relation and current amplitude are distinct and separable in newborn myocytes, and the effect on activation voltage depends on the @COMPOUND$ status of @PROTEIN$ channels.	1
569	Thus, the action of @COMPOUND$ on the activation relation and current amplitude are distinct and separable in newborn myocytes, and the effect on activation voltage depends on the cAMP status of @PROTEIN$ channels.	1
570	In contrast to newborn myocytes, @COMPOUND$ had no effect on @PROTEIN$ under control conditions in adult myocytes but induced a negative shift with no change in amplitude when saturated cAMP was added to the pipette solution.	0
571	In contrast to newborn myocytes, erbstatin had no effect on @PROTEIN$ under control conditions in adult myocytes but induced a negative shift with no change in amplitude when saturated @COMPOUND$ was added to the pipette solution.	0
572	The characterization for the binding of calcium and @COMPOUND$ to Euplotes octocarinatus @PROTEIN$.	1
573	@COMPOUND$ (SU) treatment restores insulin secretion in patients with @PROTEIN$ mutations.	0
574	@COMPOUND$ (SU) treatment restores @PROTEIN$ secretion in patients with KCNJ11 mutations.	1
575	Responses of limbic and extrapyramidal @PROTEIN$ systems to @COMPOUND$ treatment.	1
576	At the same time, both types of conduits were permeable to three compounds tested including @COMPOUND$, lysozyme and bovine @PROTEIN$, indicating the suitability of the conduits for free exchanges of nutrients.	0
577	At the same time, both types of conduits were permeable to three compounds tested including @COMPOUND$, @PROTEIN$ and bovine serum albumin, indicating the suitability of the conduits for free exchanges of nutrients.	0
578	Effects of @COMPOUND$ on breast cancer cell migration and invasion through the @PROTEIN$ cytoskeleton.	1
579	Packed cell volume, total protein, creatinine, blood @COMPOUND$ nitrogen, and @PROTEIN$ concentrations decreased while foals were on PN, while serum chloride concentration increased.	0
580	Packed cell volume, total protein, creatinine, blood urea nitrogen, and @PROTEIN$ concentrations decreased while foals were on PN, while serum @COMPOUND$ concentration increased.	0
581	Packed cell volume, total protein, creatinine, blood urea @COMPOUND$, and @PROTEIN$ concentrations decreased while foals were on PN, while serum chloride concentration increased.	0
582	Packed cell volume, total protein, @COMPOUND$, blood urea nitrogen, and @PROTEIN$ concentrations decreased while foals were on PN, while serum chloride concentration increased.	0
583	Previous studies have shown that wounding of human corneal epithelial cells (HCECs) results in the release of G-protein-coupled receptor ligands such as @COMPOUND$ and lysophosphatidic acid (LPA), which in turn transactivate epidermal growth factor (EGF) receptor (@PROTEIN$) through ectodomain shedding of heparin-binding EGF-like growth factor (HB-EGF).	1
584	Previous studies have shown that wounding of human corneal epithelial cells (HCECs) results in the release of G-protein-coupled receptor ligands such as ATP and @COMPOUND$ (LPA), which in turn transactivate epidermal growth factor (EGF) receptor (EGFR) through ectodomain shedding of heparin-binding EGF-like growth factor (@PROTEIN$).	1
585	Previous studies have shown that wounding of human corneal epithelial cells (HCECs) results in the release of G-protein-coupled receptor ligands such as @COMPOUND$ and lysophosphatidic acid (LPA), which in turn transactivate @PROTEIN$ (EGF) receptor (EGFR) through ectodomain shedding of heparin-binding EGF-like growth factor (HB-EGF).	1
586	Previous studies have shown that wounding of human corneal epithelial cells (HCECs) results in the release of G-protein-coupled receptor ligands such as ATP and @COMPOUND$ (LPA), which in turn transactivate epidermal growth factor (EGF) receptor (@PROTEIN$) through ectodomain shedding of heparin-binding EGF-like growth factor (HB-EGF).	1
587	Previous studies have shown that wounding of human corneal epithelial cells (HCECs) results in the release of G-protein-coupled receptor ligands such as ATP and @COMPOUND$ (LPA), which in turn transactivate epidermal growth factor (@PROTEIN$) receptor (EGFR) through ectodomain shedding of heparin-binding EGF-like growth factor (HB-EGF).	1
588	Previous studies have shown that wounding of human corneal epithelial cells (HCECs) results in the release of G-protein-coupled receptor ligands such as ATP and @COMPOUND$ (LPA), which in turn transactivate @PROTEIN$ (EGF) receptor (EGFR) through ectodomain shedding of heparin-binding EGF-like growth factor (HB-EGF).	1
589	Previous studies have shown that wounding of human corneal epithelial cells (HCECs) results in the release of G-protein-coupled receptor ligands such as @COMPOUND$ and lysophosphatidic acid (LPA), which in turn transactivate epidermal growth factor (@PROTEIN$) receptor (EGFR) through ectodomain shedding of heparin-binding EGF-like growth factor (HB-EGF).	1
590	Previous studies have shown that wounding of human corneal epithelial cells (HCECs) results in the release of G-protein-coupled receptor ligands such as @COMPOUND$ and lysophosphatidic acid (LPA), which in turn transactivate epidermal growth factor (EGF) receptor (EGFR) through ectodomain shedding of heparin-binding EGF-like growth factor (@PROTEIN$).	1
591	The cell proliferation, the up-regulation of pS2, and the down-regulation of @PROTEIN$ and ERbeta gene expressions induced by the racemate and enantiomers of o,p'-DDT were all reversed by cotreatment with 10(-6) mol/L @COMPOUND$.	1
592	The cell proliferation, the up-regulation of pS2, and the down-regulation of ERalpha and @PROTEIN$ gene expressions induced by the racemate and enantiomers of o,p'-DDT were all reversed by cotreatment with 10(-6) mol/L @COMPOUND$.	1
593	A specific @COMPOUND$-labelled probe, obtained by PCR amplification of a 270-bp fragment of the gene coding the LCDV @PROTEIN$, was used for ISH.	1
594	In all cases, the phenotype of SVQ524 was nearly overcome by the addition of @COMPOUND$ or cobalamin to the plant growth media or by the presence of a copy of the @PROTEIN$ gene in cosmid pMUS756.	0
595	In all cases, the phenotype of SVQ524 was nearly overcome by the addition of methionine or @COMPOUND$ to the plant growth media or by the presence of a copy of the @PROTEIN$ gene in cosmid pMUS756.	0
